Author: Ravi Shankar

WAUSAU, Wis., Oct. 26, 2026 (GLOBE NEWSWIRE) — PSB Holdings, Inc. (“PSB”) (OTCQX: PSBQ), the holding company for Peoples State Bank (“Peoples”) serving Northcentral and Southeastern Wisconsin reported earnings for the second quarter ending September 30, 2026 of $0.94 per diluted common share on net income of $3.8 million, compared to $0.81 per diluted common share on net income of $3.3 million during the second quarter ending June 30, 2026, and $0.86 per diluted common share on net income of $3.5 million during the third quarter ending September 30, 2025.

PSB’s third quarter of 2026 operating results reflected the following changes from the second quarter of 2026: (1) an increase in net interest margin due primarily to lower costing funds; (2) higher provision for credit losses on loans; (3) slightly lower non-interest income; (4) lower non-interest expenses due to a decrease in salary and employee benefits from fewer employees; and (5) slightly lower expenses associated with the merger.

PSB announced on May 19, 2026 that it entered into an Agreement and Plan of Merger with Bank First Corporation (“Bank First”), under which Bank First will acquire 100% of the common stock of PSB in an all-stock transaction. Under the terms of the Agreement and Plan of Merger, each PSB shareholder will have the right to receive 0.3470 of a share of Bank First’s common stock in exchange for each share of PSB’s common stock. The aggregate consideration is valued at approximately $202.9 million, based on the closing price of Bank First common stock as of May 18, 2026, of $143.66 per share.

“We delivered strong third quarter earnings, supported by an improved net interest margin and additional efficiencies we gained in preparation for our merger with Bank First. We remain on track for closing the merger on December 4, 2026, and have received all required shareholder and regulatory approvals,” stated Scott Cattanach, President and CEO.

September 30, 2026, Highlights:

• Net interest income increased $348,000 to $12.5 million for the quarter ended September 30, 2026, from $12.1 million for the quarter ended June 30, 2026, due in part to higher average loan balances and lower costs on time deposits.

• Noninterest income decreased $92,000 to $2.0 million for the quarter ended September 30, 2026, compared to $2.1 million the prior quarter, partially due to lower mortgage banking income.

• Noninterest expenses decreased $745,000 to $9.0 million during the quarter ended September 30, 2026 from $9.7 million for the quarter ended June 30, 2026, reflecting lower salary and benefit plan expenses related to lower incentive accruals for fiscal 2026 and staff reductions. Merger expenses were $592,000 for the third quarter ending September 30, 2026 compared to $671,000 for the quarter ended June 30, 2026. The third quarter ended September 30, 2026 reflects severance expenses totaling $423,000.

• Net loans decreased $10 million in the third quarter ended September 30, 2026, to $1.12 billion compared to $1.13 billion at June 30, 2026. Allowance for credit losses decreased to 1.12% of gross loans.

• Non-performing assets decreased to 1.02% of total assets at September 30, 2026, compared to 1.08% the previous quarter.

• Total deposits increased $34.8 million to $1.21 billion at September 30, 2026, from $1.18 billion at June 30, 2026. Core deposits increased $58.6 million and brokered deposits decreased $20.0 million.

• Return on average tangible common equity was 11.98% for the quarter ended September 30, 2026 compared to 10.62% the prior quarter and 12.14% in the year ago quarter. Tangible book value per common share was up 6.68% over the past year to $30.99 at September 30, 2026, compared to $29.05 at September 30, 2025.

Balance Sheet and Asset Quality Review

Total assets increased $5.91 million during the third quarter to $1.51 billion at September 30, 2026. Cash and cash equivalents increased $27.11 million to $84.8 million at September 30, 2026, from $57.7 million at June 30, 2026, as funds from new deposits were held in liquid investments. Investment securities available for sale decreased $12.3 million to $152.7 million at September 30, 2026, from $165.0 million one quarter earlier.

Gross loans receivable decreased $11.9 million to $1.16 billion at September 30, 2026, compared to three months earlier. Construction and development loans decreased $14.7 million to $53.4 million at September 30, 2026 and commercial & industrial loans decreased $8.0 million to $149.9 million over the three month period. Residential real estate loans decreased $3.1 million from the prior quarter to $328.5 million. Partially offsetting these loan decreases, commercial real estate loans increased $13.8 million to $603.8 million at September 30, 2026, compared to three months earlier. The loan portfolio remains well diversified with commercial real estate and construction loans totaling 56.8% of gross loans, followed by residential real estate loans at 28.4% of gross loans, commercial non-real estate loans at 14.3% and consumer loans at 0.5%.

The allowance for credit losses decreased to 1.12% of gross loans at September 30, 2026 while annualized net charge-offs to average loans were 0.53% for the quarter ended September 30, 2026. The elevated charge-offs for the quarter ended September 30, 2026 relates to a charge-off of $1.1 million on one non-accruing equipment dealership loan. Non-performing assets decreased to 1.02% of total assets at September 30, 2026, down from 1.08% at June 30, 2026. Approximately 69% of all non-performing assets consisted of five lending relationships.

Total deposits increased $34.8 million from the prior quarter to $1.21 billion. Growth in deposits was led by interest-bearing demand and savings deposits, which increased $33.0 million during the third quarter followed by an increase in non-interest bearing demand deposits of $24.8 million and an increase in money market deposits of $8.6 million during the third quarter. Partially offsetting the increase in these core deposits was a decline in retail time and local deposits of $11.5 million and a decline in brokered deposits of $20.0 million.

FHLB advances decreased by $23.0 million to $128.5 million at September 30, 2026 from $151.5 million at June 30, 2026.

Tangible stockholder equity as a percentage of total tangible assets was 8.76% at September 30, 2026, compared to 8.87% at June 30, 2026, and 8.34% at September 30, 2025, respectively.

Tangible net book value per common share increased $1.94 to $30.99 at September 30, 2026, compared to $29.05 one year earlier, an increase of 6.7% after dividends totaling $0.88 per share were paid to shareholders. Relative to the prior quarter’s tangible book value per common share of $31.27, tangible net book value per common share decreased primarily due to an increase in accumulated other comprehensive losses related to rising interest rates and the payment of dividends offset by earnings. The accumulated other comprehensive loss on the investment portfolio increased to $17.3 million at September 30, 2026 compared to $13.0 million one quarter earlier and $14.2 million at September 30, 2025.

Operations Review

Net interest income increased to $12.5 million (on a net margin of 3.48%) for the third quarter of 2026, from $12.1 million (on a net margin of 3.44%) for the second quarter of 2026, and increased from $11.3 million (on a net margin of 3.16%) for the third quarter of 2025. Higher net interest income in the current period primarily relates to a decrease in funding costs during the third quarter.

Overall funding costs decreased 5 basis points to 2.81% during the third quarter of 2026 from 2.86% the prior period. Relative to one year earlier, funding costs were down 20 basis points while yields on assets increased 11 basis points. The decrease in funding costs was due to lower deposit costs and lower costs related to FHLB advances. Deposits costs decreased 8 basis points to 1.92% for the quarter ended September 30, 2026, from 2.00% the prior quarter. FHLB advance costs declined 2 basis points to 4.04% for the second quarter from 4.06% the prior quarter.

Overall earning-asset yields declined during the current quarter due to lower yields on loans and investment securities. Loan yields declined 3 basis points to 6.10% for the quarter ended September 30, 2026 from 6.13% the prior quarter. Taxable security yields were 3.12% for the quarter ended September 30, 2026, compared to 3.22% for the quarter ended June 30, 2026, while a smaller balance of tax-exempt security yields decreased to 3.33% for the quarter ended September 30, 2026 from 3.34% the prior quarter.

Total noninterest income decreased $92,000 during the third quarter of 2026 to $2.0 million from $2.1 million in the second quarter. The third quarter reflects increases in investment and insurance sales commissions that are offset by a decline in mortgage banking income.

Noninterest expenses decreased $0.7 million to $9.0 million for the third quarter of 2026, compared to $9.7 million for the second quarter, and increased $0.1 million from $8.8 million for the third quarter of 2025. The third quarter noninterest expense levels were lower than the prior quarter due to slightly lower expenses associated with the merger which include severance payments and professional fees. Salary and benefits expenses decreased $548,000 due to lower incentive accruals and staff reductions.

Income taxes increased $58,000 during the third quarter to $892,000 from $834,000 one quarter earlier. The effective tax rate for the quarter ended September 30, 2026 was 18.5% compared to 19.7% for the second quarter ended June 30, 2026 and 16.7% for the third quarter ended September 30, 2025.

About PSB Holdings, Inc.

PSB Holdings, Inc. is the parent company of Peoples State Bank. Peoples is a community bank headquartered in Wausau, Wisconsin, serving northcentral and southeastern Wisconsin from twelve full-service banking locations in Marathon, Oneida, Vilas, Portage, Milwaukee and Waukesha counties. Peoples also provides investment and insurance products, along with retirement planning services, through Peoples Wealth Management, a division of Peoples. PSB Holdings, Inc. is traded under the stock symbol PSBQ on the OTCQX Market. More information about PSB, its management, and its financial performance may be found at www.psbholdingsinc.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on current expectations, estimates and projections about PSB’s business based, in part, on assumptions made by management and include, without limitation, statements with respect to the potential growth of PSB, its future profits, expected stock repurchase levels, future dividend rates, future interest rates, and the adequacy of its capital position. Forward-looking statements can be affected by known and unknown risks, uncertainties, and other factors, including, but not limited to, strength of the economy, the effects of government policies, including interest rate policies, risks associated with the execution of PSB’s vision and growth strategy, including with respect to current and future M&A activity, and risks associated with global economic instability. The forward-looking statements in this press release speak only as of the date on which they are made and PSB does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release.

PSB Holdings, Inc.
Consolidated Balance Sheets
September 30, June 30, and March 31, 2026, and September 30, 2025, unaudited, December 31, 2025 derived from audited financial statements
	Sep. 30,			Jun. 30,			Mar. 31,			Dec. 31,			Sep. 30,
(dollars in thousands, except per share data)		2026			2026			2026			2025			2025
Assets
Cash and due from banks	$	14,359		$	17,321		$	28,053		$	19,697		$	14,221
Interest-bearing deposits		2,324			3,283			1,703			2,262			3,630
Federal funds sold		68,099			37,073			29,755			7,916			19,641
Cash and cash equivalents		84,782			57,677			59,511			29,875			37,492
Securities available for sale (at fair value)		152,671			165,006			171,107			184,265			190,709
Securities held to maturity (fair values of $64,537, $71,765, $72,485, $76,671 and $76,104 respectively)		76,362			76,718			78,826			81,511			82,195
Equity securities		2,922			2,913			2,904			2,892			2,885
Loans held for sale		1,598			–			652			180			145
Loans receivable, net (allowance for credit losses of $12,675, $13,447, $13,131, $12,605 and $12,686 respectively)		1,123,604			1,134,370			1,116,089			1,096,035			1,115,137
Accrued interest receivable		4,779			4,885			5,094			5,035			5,023
Foreclosed assets		137			138			–			–			–
Premises and equipment, net		12,605			12,887			13,160			12,972			13,355
Mortgage servicing rights, net		1,980			1,974			1,978			1,689			1,685
Federal Home Loan Bank stock (at cost)		8,424			8,374			7,995			8,090			8,641
Cash surrender value of bank-owned life insurance		24,322			24,139			24,453			25,425			25,242
Core deposit intangible		229			247			266			287			309
Goodwill		3,565			3,565			3,565			3,495			3,495
Other assets		10,549			9,725			9,784			9,721			10,420
TOTAL ASSETS	$	1,508,529		$	1,502,618		$	1,495,384		$	1,461,472		$	1,496,733
Liabilities
Non-interest-bearing deposits	$	315,361		$	290,604		$	281,947		$	278,302		$	278,615
Interest-bearing deposits		897,616			887,579			905,082			898,729			910,571
Total deposits		1,212,977			1,178,183			1,187,029			1,177,031			1,189,186
Federal Home Loan Bank advances		128,450			151,450			136,950			112,950			140,950
Other borrowings		–			2,447			4,119			5,397			6,062
Senior subordinated notes		4,793			4,791			4,789			4,788			4,786
Junior subordinated debentures		13,202			13,177			13,151			13,126			13,100
Allowance for credit losses on unfunded commitments		492			492			492			542			622
Accrued expenses and other liabilities		12,971			15,323			14,986			15,967			13,651
Total liabilities		1,372,885			1,365,863			1,361,516			1,329,801			1,368,357
Stockholders’ equity
Preferred stock – no par value:
Authorized – 30,000 shares; Issued – 7,200 shares
Outstanding – 7,200 shares, respectively		7,200			7,200			7,200			7,200			7,200
Common stock – no par value with a stated value of $1.00 per share:
Authorized – 18,000,000 shares; Issued – 5,490,798 shares
Outstanding – 4,022,731, 4,021,558, 4,020,508, 4,023,874 and 4,040,538 shares, respectively		1,830			1,830			1,830			1,830			1,830
Additional paid-in capital		8,854			8,801			8,732			8,727			8,707
Retained earnings		158,798			155,700			153,146			150,556			148,029
Accumulated other comprehensive income (loss), net of tax		(17,297	)		(13,016	)		(13,264	)		(13,000	)		(14,166	)
Treasury stock, at cost – 1,468,067, 1,469,240, 1,470,290, 1,466,924 and 1,450,260 shares, respectively		(23,741	)		(23,760	)		(23,776	)		(23,642	)		(23,224	)
Total stockholders’ equity		135,644			136,755			133,868			131,671			128,376
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	1,508,529		$	1,502,618		$	1,495,384		$	1,461,472		$	1,496,733

PSB Holdings, Inc.
Consolidated Statements of Income
	Quarter Ended																Nine Months Ended
(dollars in thousands,	Sep. 30,			Jun. 30,			Mar. 31,			Dec. 31,			Sep. 30,				September
except per share data – unaudited)		2026			2026			2026			2025			2025				2026			2025
Interest and dividend income:
Loans, including fees	$	17,517		$	17,370		$	17,066		$	16,744		$	16,745			$	51,953		$	49,037
Securities:
Taxable		1,343			1,428			1,586			1,659			1,645				4,357			4,852
Tax-exempt		459			467			484			495			500				1,410			1,523
Other interest and dividends		664			508			316			582			717				1,488			1,394
Total interest and dividend income		19,983			19,773			19,452			19,480			19,607				59,208			56,806
Interest expense:
Deposits		5,735			5,836			5,898			5,976			6,207				17,469			18,025
FHLB advances		1,429			1,478			1,344			1,428			1,707				4,251			5,398
Other borrowings		21			13			25			40			45				59			140
Senior subordinated notes		59			58			59			59			59				176			176
Junior subordinated debentures		248			245			242			248			247				735			745
Total interest expense		7,492			7,630			7,568			7,751			8,265				22,690			24,484
Net interest income		12,491			12,143			11,884			11,729			11,342				36,518			32,322
Provision for credit losses		725			325			475			275			138				1,525			365
Net interest income after provision for credit losses		11,766			11,818			11,409			11,454			11,204				34,993			31,957
Noninterest income:
Service fees		436			424			393			401			363				1,253			1,087
Mortgage banking income		354			427			405			413			363				1,186			1,024
Investment and insurance sales commissions		435			382			437			520			345				1,254			1,006
Net loss on sale of securities		–			–			(502	)		–			–				(502	)		(1	)
Increase in cash surrender value of life insurance		183			178			175			182			176				536			509
Life insurance death benefit		–			4			489			–			–				493			–
Other noninterest income		620			705			923			565			678				2,248			2,262
Total noninterest income		2,028			2,120			2,320			2,081			1,925				6,468			5,887
Noninterest expense:
Salaries and employee benefits		5,059			5,607			5,948			5,159			5,446				16,614			15,576
Occupancy and facilities		689			697			800			712			712				2,186			2,217
Loss (gain) on foreclosed assets		9			(1	)		(36	)		(23	)		1				(28	)		(57	)
Data processing and other office operations		1,054			1,129			1,119			1,188			1,122				3,302			3,512
Advertising and promotion		161			227			189			177			138				577			456
Core deposit intangible amortization		18			19			21			21			22				58			68
Expenses associated with merger		592			671			120			26			–				1,383			26
Other noninterest expenses		1,377			1,355			1,637			1,376			1,365				4,369			4,170
Total noninterest expense		8,959			9,704			9,798			8,636			8,806				28,461			25,968
Income before provision for income taxes		4,835			4,234			3,931			4,899			4,323				13,000			11,876
Provision for income taxes		892			834			495			883			720				2,221			1,945
Net income	$	3,943		$	3,400		$	3,436		$	4,016		$	3,603			$	10,779		$	9,931
Preferred stock dividends declared	$	122		$	122		$	122		$	122		$	122			$	366		$	366
Net income available to common shareholders	$	3,821		$	3,278		$	3,314		$	3,894		$	3,481			$	10,413		$	9,565
Basic earnings per common share	$	0.95		$	0.82		$	0.82		$	0.97		$	0.86			$	2.59		$	2.35
Diluted earnings per common share	$	0.94		$	0.81		$	0.82		$	0.97		$	0.86			$	2.57		$	2.35

PSB Holdings, Inc.
Quarterly Financial Summary
(dollars in thousands, except per share data)	Quarter ended
	Sep. 30,			Jun. 30,			Mar. 31,			Dec. 31,			Sep. 30,
Earnings and dividends:		2026			2026			2026			2025			2025
Interest income	$	19,983		$	19,773		$	19,452		$	19,480		$	19,607
Interest expense	$	7,492		$	7,630		$	7,568		$	7,751		$	8,265
Net interest income	$	12,491		$	12,143		$	11,884		$	11,729		$	11,342
Provision for credit losses	$	725		$	325		$	475		$	275		$	138
Other noninterest income	$	2,028		$	2,120		$	2,320		$	2,081		$	1,925
Other noninterest expense	$	8,959		$	9,704		$	9,798		$	8,636		$	8,806
Net income available to common shareholders	$	3,821		$	3,278		$	3,314		$	3,894		$	3,481
Basic earnings per common share (3)	$	0.95		$	0.82		$	0.82		$	0.97		$	0.86
Diluted earnings per common share (3)	$	0.94		$	0.81		$	0.82		$	0.97		$	0.86
Dividends declared per common share (3)	$	0.18		$	0.18		$	0.18		$	0.34		$	–
Tangible net book value per common share (4)	$	30.99		$	31.27		$	30.55		$	29.99		$	29.05
Average common shares outstanding		4,021,762			4,020,787			4,021,327			4,028,368			4,041,393
Balance sheet – average balances:
Loans receivable, net of allowances for credit loss	$	1,126,958		$	1,124,806		$	1,118,837		$	1,107,114		$	1,111,055
Assets	$	1,500,877		$	1,491,283		$	1,478,103		$	1,501,135		$	1,510,272
Deposits	$	1,185,147		$	1,172,036		$	1,175,510		$	1,199,363		$	1,191,002
Stockholders’ equity	$	137,966		$	135,416		$	134,946		$	131,606		$	125,342
Performance ratios:
Return on average assets (1)		1.04	%		0.91	%		0.94	%		1.06	%		0.95	%
Return on average common stockholders’ equity (1)		11.59	%		10.25	%		10.52	%		12.42	%		11.69	%
Return on average tangible common stockholders’ equity (1)(4)		11.98	%		10.62	%		10.90	%		12.86	%		12.14	%
Net loan charge-offs to average loans (1)		0.53	%		0.00	%		0.00	%		0.16	%		0.00	%
Nonperforming loans to gross loans		1.34	%		1.40	%		1.44	%		1.56	%		1.51	%
Nonperforming assets to total assets		1.02	%		1.08	%		1.09	%		1.18	%		1.13	%
Allowance for credit losses to gross loans		1.12	%		1.17	%		1.16	%		1.14	%		1.12	%
Nonperforming assets to tangible equity plus the allowance for credit losses (4)		11.30	%		11.80	%		12.13	%		13.10	%		13.17	%
Net interest rate margin (1)(2)		3.48	%		3.44	%		3.45	%		3.28	%		3.16	%
Net interest rate spread (1)(2)		2.73	%		2.72	%		2.69	%		2.53	%		2.42	%
Service fee revenue as a percent of average demand deposits (1)		0.59	%		0.63	%		0.58	%		0.55	%		0.52	%
Noninterest income as a percent of gross revenue		9.21	%		9.68	%		10.66	%		9.65	%		8.94	%
Efficiency ratio (2)		61.10	%		67.35	%		68.24	%		61.82	%		65.47	%
Noninterest expenses to average assets (1)		2.37	%		2.61	%		2.69	%		2.28	%		2.31	%
Average stockholders’ equity less accumulated other comprehensive income (loss) to average assets		10.10	%		9.87	%		9.93	%		9.59	%		9.20	%
Tangible equity to tangible assets (4)		8.76	%		8.87	%		8.72	%		8.77	%		8.34	%
Stock price information:
High	$	54.00		$	50.50		$	28.50		$	26.30		$	26.00
Low	$	49.05		$	27.20		$	26.10		$	24.34		$	23.30
Last trade value at quarter-end	$	51.21		$	50.50		$	27.74		$	26.10		$	25.50
(1) Annualized
(2) The yield on federally tax-exempt loans and securities is computed on a tax-equivalent basis using a federal tax rate of 21%.
(3) Due to rounding, cumulative quarterly per share performance may not equal annual per share totals.
(4) Tangible stockholders’ equity excludes goodwill and core deposit intangibles.

PSB Holdings, Inc.
Consolidated Statements of Comprehensive Income
	Quarter Ended
	Sep. 30,			Jun. 30,			Mar. 31,			Dec. 31,			Sep. 30,
(dollars in thousands – unaudited)		2026			2026			2026			2025			2025
Net income	$	3,943		$	3,400		$	3,436		$	4,016		$	3,603
Other comprehensive income, net of tax:
Unrealized gain (loss) on securities available for sale		(4,525	)		118			(711	)		1,065			1,550
Reclassification adjustment for security loss included in net income		–			–			396			–			–
Accretion of unrealized loss included in net income on securities available for sale deferred tax adjustment for Wisconsin Act 19		(24	)		(32	)		(83	)		–			(26	)
Amortization of unrealized loss included in net income on securities available for sale transferred to securities held to maturity		93			93			91			90			90
Unrealized gain (loss) on interest rate swap		174			67			43			18			(2	)
Reclassification adjustment of interest rate swap settlements included in earnings		1			1			–			(7	)		(15	)
Other comprehensive income (loss)		(4,281	)		247			(264	)		1,166			1,597
Comprehensive income (loss)	$	(338	)	$	3,647		$	3,172		$	5,182		$	5,200

PSB Holdings, Inc.
Nonperforming Assets as of:
	Sep 30,			Jun 30,			Mar 31,			Dec 31,			Sep 30,
(dollars in thousands)		2026			2026			2026			2025			2025
Nonaccrual loans (excluding restructured loans)	$	15,071		$	15,242		$	15,438		$	16,436		$	16,560
Nonaccrual restructured loans		1			589			6			7			10
Restructured loans not on nonaccrual		139			277			863			865			415
Accruing loans past due 90 days or more		–			–			–			–			–
Total nonperforming loans		15,211			16,108			16,307			17,308			16,985
Other real estate owned		137			138			–			–			–
Total nonperforming assets	$	15,348		$	16,246		$	16,307		$	17,308		$	16,985
Nonperforming loans as a % of gross loans receivable		1.34	%		1.40	%		1.44	%		1.56	%		1.51	%
Total nonperforming assets as a % of total assets		1.02	%		1.08	%		1.09	%		1.18	%		1.13	%
Allowance for credit losses as a % of nonperforming loans		83.33	%		83.48	%		80.52	%		72.83	%		74.69	%

PSB Holdings, Inc.
Nonperforming Assets >= $1,000,000 net book value before specific reserves
At September 30, 2026
(dollars in thousands)
		Gross			Specific
Collateral Description	Asset Type	Principal			Reserves
Real estate – Non-Owner Occupied Rental Properties	Nonaccrual		2,639			–
Real estate – Recreational Facility	Nonaccrual		3,497			204
Real estate – Equipment Dealership	Nonaccrual		1,194			250
Real estate – Wood Products	Nonaccrual		1,674			376
Real estate – Commercial Building	Nonaccrual		1,627			54
Total listed nonperforming assets		$	10,631		$	884
Total bank wide nonperforming assets		$	15,348		$	1,394
Listed assets as a % of total nonperforming assets			69	%		63	%

PSB Holdings, Inc.
Loan Composition by Collateral Type
Quarter-ended (dollars in thousands)	Sep 30, 2026			Jun 30, 2026			Mar 31, 2026			Dec 31, 2025			Sep 30, 2025
Commercial:
Commercial and industrial	$	149,925		$	157,903		$	143,572		$	139,479		$	137,199
Agriculture		7,680			7,215			9,188			11,463			12,443
Municipal		8,024			8,258			8,481			11,317			8,361
Total Commercial		165,629			173,376			161,241			162,259			158,003
Commercial Real Estate:
Commercial real estate		603,778			590,027			578,655			551,899			569,382
Construction and development		53,422			68,107			70,757			70,574			81,278
Total Commercial Real Estate		657,200			658,134			649,412			622,473			650,660
Residential real estate:
Residential		250,152			253,189			251,356			259,573			263,791
Construction and development		29,394			29,744			34,540			36,596			37,475
HELOC		48,978			48,682			44,545			44,219			41,661
Total Residential Real Estate		328,524			331,615			330,441			340,388			342,927
Consumer installment		5,124			5,248			4,648			5,053			4,801
Subtotals – Gross loans		1,156,477			1,168,373			1,145,742			1,130,173			1,156,391
Loans in process of disbursement		(20,713	)		(21,149	)		(17,148	)		(22,178	)		(29,170	)
Subtotals – Disbursed loans		1,135,764			1,147,224			1,128,594			1,107,995			1,127,221
Net deferred loan costs		515			593			626			645			602
Allowance for credit losses		(12,675	)		(13,447	)		(13,131	)		(12,605	)		(12,686	)
Total loans receivable	$	1,123,604		$	1,134,370		$	1,116,089		$	1,096,035		$	1,115,137

PSB Holdings, Inc.
Selected Commercial Real Estate Loans by Purpose
	Sep 30,				Jun 30,				Mar 31,				Dec 31,				Sep 30,
(dollars in thousands)		2026				2026				2026				2025				2025
	Total Exposure		% of Portfolio (1)		Total Exposure		% of Portfolio (1)		Total Exposure		% of Portfolio (1)		Total Exposure		% of Portfolio (1)		Total Exposure		% of Portfolio (1)
Multi Family	$	129,365	12.3	%	$	127,983	12.3	%	$	134,236	12.9	%	$	145,717	14.3	%	$	141,896	13.5	%
Industrial and Warehousing		119,540	11.4			120,116	11.6			119,427	11.5			101,581	9.9			100,712	9.6
Retail		28,501	2.7			28,468	2.7			27,948	2.7			27,756	2.7			27,889	2.7
Hotels		27,044	2.6			24,839	2.4			25,080	2.4			25,949	2.6			25,677	2.4
Office		3,972	0.4			4,034	0.4			4,097	0.4			7,028	0.7			7,176	0.7
(1) Percentage of commercial and commercial real estate portfolio and commitments.

PSB Holdings, Inc.
Deposit Composition
Insured and Collateralized Deposits	September 30,				June 30,				March 31,				December 31,				September 30,
(dollars in thousands)		2026				2026				2026				2025				2025
	$		%		$		%		$		%		$		%		$		%
Non-interest bearing demand	$	231,406	19.0	%	$	226,134	19.1	%	$	221,921	18.5	%	$	225,025	19.1	%	$	227,448	19.1	%
Interest-bearing demand and savings		344,163	28.4	%		313,909	26.7	%		321,604	27.1	%		323,739	27.5	%		307,505	25.8	%
Money market deposits		142,930	11.7	%		141,443	12.0	%		146,655	12.4	%		142,946	12.1	%		158,455	13.3	%
Retail and local time deposits <= $250		146,566	12.1	%		154,330	13.1	%		157,898	13.3	%		163,398	13.9	%		163,446	13.7	%
Total core deposits		865,065	71.2	%		835,816	70.9	%		848,078	71.3	%		855,108	72.6	%		856,854	71.9	%
Retail and local time deposits > $250		24,000	2.0	%		25,250	2.1	%		26,500	2.2	%		28,000	2.4	%		29,000	2.5	%
Broker & national time deposits <= $250		748	0.1	%		748	0.1	%		748	0.1	%		748	0.1	%		748	0.1	%
Broker & national time deposits > $250		29,779	2.5	%		49,788	4.2	%		54,191	4.6	%		62,493	5.3	%		67,493	5.7	%
Totals	$	919,592	75.8	%	$	911,602	77.3	%	$	929,517	78.2	%	$	946,349	80.4	%	$	954,095	80.2	%
PSB Holdings, Inc.
Deposit Composition
Uninsured Deposits	September 30,				June 30,				March 31,				December 31,				September 30,
(dollars in thousands)		2026				2026				2026				2025				2025
	$		%		$		%		$		%		$		%		$		%
Non-interest bearing demand	$	83,955	6.9	%	$	64,470	5.5	%	$	60,026	5.1	%	$	53,277	4.5	%	$	51,167	4.3	%
Interest-bearing demand and savings		20,817	1.7	%		18,073	1.5	%		18,533	1.6	%		17,683	1.5	%		18,644	1.6	%
Money market deposits		141,312	11.7	%		134,223	11.4	%		128,415	10.8	%		110,501	9.4	%		117,184	9.9	%
Retail and local time deposits <= $250		–	0.0	%		–	0.0	%		–	0.0	%		–	0.0	%		–	0.0	%
Total core deposits		246,084	20.3	%		216,766	18.4	%		206,974	17.5	%		181,461	15.4	%		186,995	15.8	%
Retail and local time deposits > $250		47,301	3.9	%		49,815	4.3	%		50,538	4.3	%		49,221	4.2	%		48,096	4.0	%
Broker & national time deposits <= $250		–	0.0	%		–	0.0	%		–	0.0	%		–	0.0	%		–	0.0	%
Broker & national time deposits > $250		–	0.0	%		–	0.0	%		–	0.0	%		–	0.0	%		–	0.0	%
Totals	$	293,385	24.2	%	$	266,581	22.7	%	$	257,512	21.8	%	$	230,682	19.6	%	$	235,091	19.8	%
PSB Holdings, Inc.
Deposit Composition
Total Deposits	September 30,				June 30,				March 31,				December 31,				September 30,
(dollars in thousands)		2026				2026				2026				2025				2025
	$		%		$		%		$		%		$		%		$		%
Non-interest bearing demand	$	315,361	25.9	%	$	290,604	24.6	%	$	281,947	23.6	%	$	278,302	23.6	%	$	278,615	23.4	%
Interest-bearing demand and savings		364,980	30.1	%		331,982	28.2	%		340,137	28.7	%		341,422	29.0	%		326,149	27.4	%
Money market deposits		284,242	23.4	%		275,666	23.4	%		275,070	23.2	%		253,447	21.5	%		275,639	23.2	%
Retail and local time deposits <= $250		146,566	12.1	%		154,330	13.1	%		157,898	13.3	%		163,398	13.9	%		163,446	13.7	%
Total core deposits		1,111,149	91.5	%		1,052,582	89.3	%		1,055,052	88.8	%		1,036,569	88.0	%		1,043,849	87.7	%
Retail and local time deposits > $250		71,301	5.9	%		75,065	6.4	%		77,038	6.5	%		77,221	6.6	%		77,096	6.5	%
Broker & national time deposits <= $250		748	0.1	%		748	0.1	%		748	0.1	%		748	0.1	%		748	0.1	%
Broker & national time deposits > $250		29,779	2.5	%		49,788	4.2	%		54,191	4.6	%		62,493	5.3	%		67,493	5.7	%
Totals	$	1,212,977	100.0	%	$	1,178,183	100.0	%	$	1,187,029	100.0	%	$	1,177,031	100.0	%	$	1,189,186	100.0	%

PSB Holdings, Inc.
Average Balances ($000) and Interest Rates
(dollars in thousands)
	Quarter ended September 30, 2026								Quarter ended June 30, 2026								Quarter ended September 30, 2025
	Average					Yield /			Average					Yield /			Average					Yield /
	Balance			Interest		Rate			Balance			Interest		Rate			Balance			Interest		Rate
Assets
Interest-earning assets:
Loans (1)(2)	$	1,140,312		$	17,539	6.10	%		$	1,138,074		$	17,392	6.13	%		$	1,123,665		$	16,796	5.93	%
Taxable securities		170,836			1,343	3.12	%			177,864			1,428	3.22	%			193,277			1,645	3.38	%
Tax-exempt securities (2)		69,150			581	3.33	%			70,873			591	3.34	%			75,419			633	3.33	%
FHLB stock		8,412			178	8.40	%			8,227			170	8.29	%			9,182			201	8.68	%
Other		51,497			486	3.74	%			36,217			338	3.74	%			45,649			516	4.48	%
Total (2)		1,440,207			20,127	5.54	%			1,431,255			19,919	5.58	%			1,447,192			19,791	5.43	%
Non-interest-earning assets:
Cash and due from banks		16,552								15,689								16,122
Premises and equipment, net		12,784								13,084								13,377
Cash surrender value ins		24,208								24,026								25,130
Other assets		20,480								20,508								21,061
Allowance for credit losses		(13,354	)							(13,268	)							(12,610	)
Total	$	1,500,877							$	1,491,294							$	1,510,272
Liabilities & stockholders’ equity
Interest-bearing liabilities:
Savings and demand deposits	$	350,238		$	1,549	1.75	%		$	338,948		$	1,508	1.78	%		$	320,732		$	1,428	1.77	%
Money market deposits		278,393			1,859	2.65	%			276,290			1,783	2.59	%			281,189			1,746	2.46	%
Time deposits		264,974			2,327	3.48	%			286,959			2,545	3.56	%			310,441			3,033	3.88	%
FHLB borrowings		140,488			1,429	4.04	%			145,927			1,478	4.06	%			154,211			1,707	4.39	%
Other borrowings		4,181			21	1.99	%			3,820			13	1.37	%			6,280			45	2.84	%
Senior sub. notes		4,792			59	4.88	%			4,790			58	4.86	%			4,785			59	4.89	%
Junior sub. debentures		13,190			248	7.46	%			13,164			245	7.47	%			13,088			247	7.49	%
Total		1,056,256			7,492	2.81	%			1,069,898			7,630	2.86	%			1,090,726			8,265	3.01	%
Non-interest-bearing liabilities:
Demand deposits		291,542								269,839								278,640
Other liabilities		15,113								16,141								15,564
Stockholders’ equity		137,966								135,416								125,342
Total	$	1,500,877							$	1,491,294							$	1,510,272
Net interest income				$	12,635							$	12,289							$	11,526
Rate spread						2.73	%							2.72	%							2.42	%
Net yield on interest-earning assets						3.48	%							3.44	%							3.16	%
(1) Nonaccrual loans are included in the daily average loan balances outstanding.
(2) The yield on federally tax-exempt loans and securities is computed on a tax-equivalent basis using a federal tax rate of 21%.

PSB Holdings, Inc.
Average Balances ($000) and Interest Rates
(dollars in thousands)
	Nine months ended September 30, 2026									Nine months ended September 30, 2025
	Average						Yield/			Average						Yield/
	Balance			Interest			Rate			Balance			Interest			Rate
Assets
Interest-earning assets:
Loans (1)(2)	$	1,136,751		$	52,023		6.12	%		$	1,117,079		$	49,183		5.89	%
Taxable securities		179,407			4,357		3.25	%			195,191			4,852		3.32	%
Tax-exempt securities (2)		71,164			1,785		3.35	%			77,144			1,928		3.34	%
FHLB stock		8,146			530		8.70	%			9,067			608		8.97	%
Other		34,123			958		3.75	%			23,193			786		4.53	%
Total (2)		1,429,591			59,653		5.58	%			1,421,674			57,357		5.39	%
Non-interest-earning assets:
Cash and due from banks		15,989									15,970
Premises and equipment, net		12,941									13,543
Cash surrender value ins		24,487									24,963
Other assets		20,348									21,161
Allowance for credit losses		(13,188	)								(12,477	)
Total	$	1,490,168								$	1,484,834
Liabilities & stockholders’ equity
Interest-bearing liabilities:
Savings and demand deposits	$	344,099		$	4,624		1.80	%		$	325,470		$	4,445		1.83	%
Money market deposits		272,210			5,259		2.58	%			274,520			5,003		2.44	%
Time deposits		282,862			7,586		3.59	%			291,490			8,577		3.93	%
FHLB borrowings		138,403			4,251		4.11	%			164,047			5,398		4.40	%
Other borrowings		4,257			59		1.85	%			7,148			140		2.62	%
Senior sub. notes		4,790			176		4.91	%			4,784			176		4.92	%
Junior sub. debentures		13,164			735		7.47	%			13,062			745		7.63	%
Total		1,059,785			22,690		2.86	%			1,080,521			24,484		3.03	%
Non-interest-bearing liabilities:
Demand deposits		278,565									266,566
Other liabilities		15,875									15,358
Stockholders’ equity		135,943									122,389
Total	$	1,490,168								$	1,484,834
Net interest income				$	36,963								$	32,873
Rate spread							2.72	%								2.36	%
Net yield on interest-earning assets							3.46	%								3.09	%
(1) Nonaccrual loans are included in the daily average loan balances outstanding.
(2) The yield on federally tax-exempt loans and securities is computed on a tax-equivalent basis using a federal tax rate of 21%.

Investor Relations Contact
PSB Holdings, Inc.
1905 Stewart Avenue
Wausau, WI 54401
888.929.9902
InvestorRelations@bankpeoples.com

If issued, the patent will become the Korean subsidiary’s seventh U.S. patent, expanding its intellectual property portfolio for AI-based fire and disaster safety technologies

SEONGNAM, South Korea, Oct. 26, 2026 (GLOBE NEWSWIRE) — Roze AI Inc. (Nasdaq: RZAI) (“Roze AI” or the “Company”), a Physical AI technology company, announced that its wholly owned subsidiary, Roze AI Korea Co., Ltd., has received a Notice of Allowance from the United States Patent and Trademark Office (“USPTO”) for its U.S. patent application titled “Shortest Evacuation Route System and Operation Method Using the Same.”

Final patent issuance is subject to completion of applicable USPTO procedures.

The patent application covers a system and operating method designed to support safe evacuation during a fire or other emergency. The technology calculates evacuation routes by factoring in real-time evacuee movement and changing fire hazards, and displays those routes across connected guidance devices.

Roze AI Korea Co., Ltd. also holds a Korean patent related to this technology (Korean Patent No. 10-3033491).

If issued, the patent would become Roze AI Korea Co., Ltd.’s seventh issued U.S. patent. The Company continues to expand its intellectual property portfolio in the United States and South Korea, focusing on advanced technologies related to fire detection, risk assessment, fire protection and disaster response.

Key U.S. patents issued to Roze AI Korea Co., Ltd. include:

• Fire Alarm Apparatus for Unwanted Alarm – a fire alarm apparatus for reducing unwanted or non-fire alarms (U.S. Patent No. 12,525,122 B2)
• Fire Prevention System and Evaluation Tool Calculation Method Using Same – technology for visualized fire risk assessment (U.S. Patent No. 12,456,364 B2)
• Fire Protection Method and Fire Protection System – a fire protection method and system (U.S. Patent No. 12,456,358 B2)

Global IP Strategy to Strengthen Technology Competitiveness

Young Jin Cho, Chief Executive Officer of Roze AI, said:

“Since its founding, Roze AI has pursued a strategy of protecting our core innovations through disciplined research and development and targeted patent filings. As we continue to advance our AI-based fire prediction and disaster safety technologies, expanding our patent portfolio primarily in the United States and South Korea remains a top priority.”

He added, “This Notice of Allowance is significant because it represents a step toward securing U.S. patent protection for technology that supports real-time decision-making during evacuation, extending beyond traditional fire detection and alarm systems.”

About Roze AI Inc.

Roze AI is a Canadian Physical AI technology company operating through its wholly owned subsidiary, Roze AI Korea Co., Ltd., in Seongnam, South Korea.

The Company’s Disaster AI Platform (DAP) analyzes sensor and facility data using AI and digital twin technology to generate a Fire Risk Index that supports fire risk assessment, monitoring and early warning.

Through Roze AI Korea Co., Ltd., the Company develops and provides Fire 4Cast, Disaster AI Platform (DAP) and other solutions for buildings, facilities and urban infrastructure.

For more information, please visit www.rozeai.com.

Investor / Media Relations

Roze AI Inc.
Email: ir@rozeai.com

Investor Relations – North America

Jack Perkins
KCSA Strategic Communications
Email: rozeai@kcsa.com

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements under applicable U.S. federal securities laws, including the Private Securities Litigation Reform Act of 1995. These statements include the anticipated issuance of this patent and the resulting number of issued U.S. patents held by Roze AI Korea Co., Ltd.; the Company’s intellectual property strategy and future patent filings and protection; research and technology development plans; and future applications of its technologies.

These forward-looking statements reflect management’s expectations, estimates and assumptions based on currently available information and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied.

These risks and uncertainties include delays or changes in the patent issuance process and completion of applicable USPTO requirements; the scope, validity and enforceability of patent protection; the Company’s ability to obtain, maintain and protect its intellectual property rights; technology development and application; competition, regulatory requirements and market conditions; and risk factors described in the Company’s reports and other filings with the U.S. Securities and Exchange Commission (“SEC”).

Readers should not place undue reliance on forward-looking statements, which speak only as of the date of this release. The Company undertakes no obligation to publicly update or revise these statements as a result of new information, future events or otherwise, except as required by applicable law.

SOUTH SAN FRANCISCO, Calif., Oct. 26, 2026 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) products for cancer and autoimmune disease, today announced that it will participate in the following upcoming investor conferences in November and December 2026.

• UBS Global Biopharma Conference
  Monday, November 16
  11:20 AM GMT / 6:20 AM ET
  London

• Jefferies Global Healthcare Conference
  Wednesday, November 18
  9:30 AM GMT / 5:30 AM ET
  London

• Piper Sandler 38th Annual Healthcare Conference
  Wednesday, December 2
  Time TBD
  New York

Any available webcasts will be posted to the Company’s website at www.allogene.com under the Investors tab in the News and Events section. Following a live webcast, a replay will be available on the Company’s website for approximately 30 days.

About Allogene Therapeutics
Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer and autoimmune disease. Led by cell therapy veterans applying proven CAR T experience, Allogene is developing a pipeline of off-the-shelf CAR T cell product candidates with the goal of delivering readily available cell therapy on-demand, more reliably, and at greater scale to more patients. For more information, please visit www.allogene.com, and follow Allogene Therapeutics on X and LinkedIn.

Cautionary Note on Forward-Looking Statements for Allogene
This press release contains forward-looking statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements regarding intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things Allogene’s ability to develop and deliver readily available allogeneic CAR T products for the treatment of cancer and autoimmune disease on-demand, more reliably, and at greater scale to more patients. Various factors may cause material differences between Allogene’s expectations and actual results, including risks and uncertainties related to our product candidates being based on novel technologies, which makes it difficult to predict the time and cost of product candidate development, the safety or efficacy of a product candidate, and whether a product candidate will receive regulatory approval, which could prevent or delay commercialization. These and other risks are discussed in greater detail in Allogene’s filings with the SEC, including without limitation under the “Risk Factors” heading in its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026. Any forward-looking statements that are made in this press release speak only as of the date of this press release. Allogene assumes no obligation to update the forward-looking statements whether as a result of new information, future events or otherwise, after the date of this press release.

Allogene Media/Investor Contact:
Christine Cassiano
EVP, Chief Corporate Affairs & Brand Strategy Officer
Christine.Cassiano@allogene.com

Adds In-House Machining, Repair, and Rebuild Capabilities to ADT’s Vernal Operation

OLD GREENWICH, Conn., Oct. 26, 2026 (GLOBE NEWSWIRE) — Star Equity Holdings, Inc. (Nasdaq: STRR and STRRP) (“Star” or the “Company”), a diversified holding company, announced today that its wholly owned Alliance Drilling Tools (“ADT”) business, part of the Company’s Energy Services division, has expanded its customer support capabilities in the Rocky Mountain region through an affiliate’s acquisition of a privately held Vernal, Utah-based machine shop that provides repair, rebuild, and machining services for well fishing tools, drill pipe, and other drilling equipment. The transaction closed on October 23, 2026, and the shop will work alongside ADT’s existing Vernal operation.

The acquisition serves a critical energy services niche in the region, helping customers reduce downtime and improve rig productivity by getting essential equipment back in service quickly. The business operates from an approximately 6,300-square-foot facility on two acres located minutes from ADT’s existing Vernal operation.

Adding these in-house capabilities makes ADT’s Vernal operation a full-service location. With geographically centralized tool rental, machining, repair, and rebuild services, ADT can support customers across more of the tool life cycle while gaining more direct control over service quality and turnaround time. The expanded capabilities also position ADT to more actively pursue oil and gas drilling work in the Uinta Basin, as well as mining and geothermal opportunities across the region.

Jeff Eberwein, CEO of Star, commented, “Expanding our Energy Services division’s capabilities is a key part of our strategy to grow, and adding in-house machining in Vernal is a natural next step in that effort. With Star’s financial support and ADT’s customer base, operating platform, and equipment, we believe the Vernal shop can add capacity, take on more work, and build on its established customer relationships. We expect this addition to create long-term value for Star’s shareholders.”

Ryan Thomas, President of ADT, added, “Having our own machine shop in Vernal lets us respond faster, rely less on outside machining, and offer customers a true one-stop shop in the Uinta Basin. We have relied on this shop for our machining needs in Vernal for more than a decade, and its people are a terrific culture fit. We are excited to welcome the team.”

About Star Equity Holdings, Inc.

Star Equity Holdings, Inc. is a diversified holding company that seeks to build long-term shareholder value by acquiring, managing, and growing businesses with strong fundamentals and market opportunities. Its current structure comprises four divisions: Building Solutions, Business Services, Energy Services, and Investments. For more information, visit www.starequity.com.

Building Solutions

The Building Solutions division operates in three specialties: (i) modular building manufacturing; (ii) structural wall panel and wood foundation manufacturing, including building supply distribution operations; and (iii) glue-laminated timber (glulam) column, beam, and truss manufacturing.

Business Services

The Business Services division provides flexible and scalable recruitment solutions to a global clientele, servicing organizations at all levels, from entry-level positions to the C-suite. The division focuses on mid-market and enterprise organizations worldwide, partnering consultatively with talent acquisition, HR, and procurement leaders to build diverse, high-impact teams and drive business success.

Energy Services

The Energy Services division engages in the rental, sale, and repair of downhole tools used in the oil and gas, geothermal, mining, and water-well industries.

Investments
The Investments division manages and finances the Company’s real estate assets as well as its investment positions in private and public companies.

Forward-Looking Statements
This press release contains statements that the Company believes to be “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this press release, including statements regarding the Company’s future financial condition, results of operations, business operations, and business prospects, are forward-looking statements. Words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “predict,” “believe,” and similar words, expressions, and variations of these words and expressions are intended to identify forward-looking statements. All forward-looking statements are subject to important factors, risks, uncertainties, and assumptions, including industry and economic conditions, that could cause actual results to differ materially from those described in the forward-looking statements. Such factors, risks, uncertainties, and assumptions include, but are not limited to, (1) global economic fluctuations, (2) changes in the cost and availability of commodities, materials, and equipment, (3) risks related to providing uninterrupted service to clients, (4) the ability of clients to terminate their relationship with the Company at any time, (5) risks associated with real estate ownership, (6) the Company’s ability to successfully achieve its strategic initiatives, (7) risks related to fluctuations in the Company’s operating results from quarter to quarter, (8) risks related to potential acquisitions or dispositions of businesses by the Company, (9) our profitability and growth being tied to the success of our operating businesses, (10) risks associated with our financial investments in other businesses, (11) our ability to improve existing products and services and develop, introduce, and market new products and services successfully, (12) the loss of or material reduction in our business with any of the Company’s largest customers, (13) competition in the Company’s markets, (14) risks related to potential decreases in demand for products, (15) our ability to maintain costs at an acceptable level, (16) the negative cash flows and operating losses that may recur in the future, (17) risks related to international operations, including foreign currency fluctuations, political events, trade wars, natural disasters or health crises, including the Russia-Ukraine war, and potential conflict in the Middle East, (18) risks relating to how future credit facilities may affect or restrict our operating flexibility, (19) our ability to generate or borrow sufficient cash to make payments on our indebtedness, (20) risks related to indebtedness, (21) risks associated with the Company’s investment strategy, (22) the Company’s dependence on key management personnel, (23) the Company’s ability to attract and retain highly skilled professionals, management, and advisors, (24) the Company’s ability to collect accounts receivable, (25) the Company’s exposure to legal proceedings, investigations, and disputes, and limits on related insurance coverage, (26) the Company’s ability to utilize net operating loss carryforwards, (27) the potential for goodwill impairment, (28) volatility of the Company’s stock price, (29) risks related to our historically low trading volume, (30) risks related to securities or industry analysts, (31) the Company’s ability to declare dividends, (32) risks associated with failure to pay dividends on our Series A Preferred Stock, (33) our history of annual net losses, (34) risks related to our international operations, (35) risks related to compliance with federal and state laws, regulations, and other rules, (36) our exposure to employment-related claims, legal liability, and costs from clients, employees, and regulatory authorities, (37) risks related to the imposition of licensing or tax requirements or new regulations, (38) the effect of anti-takeover provisions in our organizational documents, (39) the effect of the protective amendment contained in our Restated Certificate of Incorporation, (40) the impact of our stockholder rights plan, or “poison pill,” on stockholder decision making, (41) risks related to our scaled disclosure requirements as a smaller reporting company, (42) the heavy reliance on information systems and the impact of potentially losing or failing to develop technology, (43) the adverse impacts of cybersecurity threats and attacks, (44) risks related to the use of new and evolving technologies, and (45) those risks set forth in “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025. The foregoing list should not be construed to be exhaustive. Actual results could differ materially from the forward-looking statements contained in this press release. In view of these uncertainties, you should not place undue reliance on any forward-looking statements, which are based on our current expectations. These forward-looking statements speak only as of the date of this press release. The Company assumes no obligation, and expressly disclaims any obligation, to update any forward-looking statements, whether as a result of new information, future events, or otherwise.

For more information, contact:

The Equity Group

Lena Cati

Senior Vice President

212-836-9611

lena.cati@theequitygroup.com

FORT LAUDERDALE, Fla., Oct. 26, 2026 (GLOBE NEWSWIRE) — via IBN – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company’s SSi Mantra surgical robotic system (the “SSi Mantra”) and SSi MantrAsana tele-surgeon console (the “SSi MantrAsana”) were showcased in successful telesurgeries performed in October 2026 during the European Association for Cardio-Thoracic Surgery (“EACTS”) Annual Meeting in Barcelona, Spain and the Society of Robotic Surgery India (“SRS India”) Conference in New Delhi, India. 

At the EACTS Annual Meeting, the Company’s Chairman of the Board and Chief Executive Officer, Dr. Sudhir Srivastava, successfully performed a robotic-assisted cardiac telesurgery utilizing the SSi Mantra and SSi MantrAsana tele-surgeon console live on stage in Barcelona, approximately 7,500 miles (12,000 kilometers) from the patient at Sri Madhusudan Sai Institute of Medical Sciences and Research in Bengaluru, India.  Dr. Srivastava remotely performed a robotic atrial septal defect (ASD) procedure with patient-side support from Dr. Lalit Malik, Chief Cardiac Surgeon of Manipal Hospital Jaipur.  The EACTS Annual Meeting is the largest global gathering of leaders in the cardiothoracic surgical community, bringing together thousands of industry professionals each year.

At the inaugural SRS India Conference, four surgeons successfully completed four separate robotic-assisted telesurgeries featuring the SSi Mantra and SSi MantrAsana tele-surgeon console in live demonstrations.  The remote procedures performed or broadcast live at the event included: a right partial nephrectomy, a right hemicolectomy, a left-sided pyeloplasty on a pediatric patient, and a modified radical hysterectomy with a sentinel lymph node biopsy.  Organized by the Society of Robotic Surgery and officially inaugurated by Dr. Jitendra Singh, India’s Minister of Science and Technology, the SRS India Conference convenes leading surgeons, delegates, researchers and industry partners in New Delhi each year.  For video highlights of the telesurgeries showcased at the SRS India Conference, please visit: link.  

Dr. Srivastava commented, “We were grateful for the opportunity to demonstrate the advanced telesurgery capabilities of our SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console this month at the 40th EACTS Annual Meeting in Barcelona and the inaugural SRS India Conference in New Delhi.  As a pioneer and leader in telesurgery technology, SS Innovations aims to dismantle traditional geographic barriers and democratize access to world class health care.”

The SSi MantrAsana has been engineered for real-time remote procedures through ultra-low latency connectivity, high-definition visualization, and precise instrument control.

As of October 23, 2026, a total of 205 telesurgeries, including intricate cardiac procedures, have been performed with the SSi Mantra surgical robotic system.  

About SS Innovations
SS Innovations International, Inc. (Nasdaq: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company’s product range includes its proprietary “SSi Mantra” surgical robotic system and its comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery.  Headquartered in India, SS Innovations is a U.S. company focused on expanding the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions.  Visit the Company’s website at ssinnovations.com or LinkedIn for more information and updates.

About the SSi Mantra
The SSi Mantra surgical robotic system is a modular, multi-arm system with advanced technology features, including: 3 to 5 modular robotic arms, an open-faced ergonomic surgeon command center, a large 3D 4K monitor, a touch panel monitor for all patient related information display, a virtual real-time image of the robotic patient side arm carts, and the ability for superimposition of 3D models of diagnostic imaging. The optional SSi MantrAsana tele-surgeon console is a portable, compact alternative to the SSi Mantra’s standard surgeon command center that is intended to provide equivalent control functionality while enabling enhanced portability, ergonomic flexibility, and telesurgery capability. The SSi Mantra utilizes over 40 different types of robotic endo-surgical instruments to support different specialties, including cardiac surgery, and 5mm instruments for the pediatric population and ENT surgeries. A vision cart is designed to provide the table-side team with the same magnified 3D 4K view as the surgeon to provide better safety and efficiency. The SSi Mantra has been clinically validated in India in more than 190 different types of surgical procedures.

Forward Looking Statements
This press release may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words “anticipate,” “assume,” “believe,” “estimate,” “expect,” “will,” “intend,” “may,” “plan,” “project,” “should,” “could,” “seek,” “designed,” “potential,” “forecast,” “target,” “objective,” “goal,” or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future events or SS Innovations’ future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

Investor Contact:
The Equity Group       
Kalle Ahl, CFA             
T: (303) 953-9878       
kalle.ahl@theequitygroup.com

Devin Sullivan, Managing Director
T: (212) 836-9608
devin.sullivan@theequitygroup.com

Media Contact:
RooneyPartners LLC
Kate Barrette
T: (212) 223-0561
kbarrette@rooneypartners.com

Attachment

• Live Cardiac Telesurgery Performed from EACTS Annual Meeting Utilizing the SSi Mantra

• Phase 2 CLOVER study enrolled 66 patients across seven sites in metastatic colorectal cancer
• Updated data show universal CCR5 expression, early ctDNA reductions and favorable tolerability

VANCOUVER, Washington, Oct. 26, 2026 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 receptor with therapeutic potential across multiple indications, including colorectal cancer (mCRC) and metastatic triple-negative breast cancer (mTNBC), today announced that updated clinical and translational data from its ongoing Phase 2 CLOVER study (ClinicalTrials.gov Identifier: NCT06699836) evaluating leronlimab in combination with trifluridine and tipiracil (TFD/TPI) plus bevacizumab in mCRC were presented at the ESMO Congress 2026, held October 23–27, 2026, in Madrid, Spain.

The poster presentation, titled “Leronlimab (LRM) in combination with trifluridine/tipiracil (TAS-102) plus bevacizumab (BEV) in metastatic colorectal cancer (mCRC): The phase 2 CLOVER study,” was presented by Benjamin Weinberg, M.D., Associate Professor at Georgetown University on Sunday, October 25, 2026, from 4:00 – 4:45 a.m. PDT (12:00 – 12:45 p.m. CET), as Poster #820P, and included updated safety and biomarker findings from the multicenter study in patients with previously treated mCRC.

CCR5 is implicated in the recruitment of immunosuppressive immune cell populations, including regulatory T cells and myeloid cells, into the tumor microenvironment and may contribute to immune evasion in colorectal cancer. The CLOVER study is evaluating the safety of adding leronlimab to TFD/TPI plus bevacizumab and whether CCR5 inhibition may enhance anti-tumor activity through immune modulation. The study’s primary efficacy endpoint is objective response rate (“ORR”), defined as the proportion of patients achieving a confirmed complete or partial response according to RECIST v1.1.

“These updated findings continue to provide important insight into the biological effects of CCR5 inhibition in metastatic colorectal cancer, particularly through the integration of tissue and blood-based biomarkers,” said Benjamin Weinberg, M.D., Associate Professor of Medicine at Georgetown University. “The consistent CCR5 expression observed across all evaluable tumor samples, together with rapid, early reductions in circulating tumor DNA, supports continued investigation of leronlimab in combination with established therapies for patients with refractory disease.”

Key findings from the Phase 2 CLOVER study include:

• 66 patients were enrolled across seven clinical sites between June 2025 and May 2026. Leronlimab was administered subcutaneously once weekly at either 350 mg or 700 mg in combination with standard doses of TFD/TPI and bevacizumab.
• CCR5 expression was detected in 100% of evaluable archival tumor samples (91/91) from pre-screened patients, further supporting investigation of CCR5 as a potential therapeutic target in mCRC.
• In 28 patients with available baseline and Week 2 ctDNA results, a median reduction of 86% in ctDNA was observed at Week 2.
• Among the 32 patients with currently available safety data, no leronlimab-related adverse events led to treatment discontinuation and no leronlimab-related adverse events greater than Grade 2 were reported. No leronlimab-related dose-limiting toxicities were observed.
• The TFD/TPI + bevacizumab + leronlimab combination demonstrated deeper ctDNA responses, with significantly greater reductions in molecular residual disease (MRD) from baseline versus TFD/TPI + bevacizumab at both 0–4 weeks (p=0.0005) and 0–8 weeks (p=0.0006), as well as deeper MRD reductions than TFD/TPI alone at both time points.

“We are encouraged by the consistent CCR5 expression across evaluable tumor samples and the early ctDNA reductions observed in patients with available data,” said Jacob P. Lalezari, M.D., Head of Research and Translational Sciences at CytoDyn. “These findings give us additional insight into how leronlimab may be interacting with the biology of metastatic colorectal cancer while maintaining a favorable tolerability profile in combination with TFD/TPI and bevacizumab. The expanded biomarker data being presented at ESMO will help further characterize these observations and inform the continued development of this program.”

A copy of the poster will be made available on CytoDyn’s website under the Publications & Posters section.

About the European Society for Medical Oncology (ESMO) Congress 2026
The ESMO Congress 2026, taking place October 23–27, 2026, in Madrid, Spain, is a leading global oncology meeting bringing together clinicians, researchers, patient advocates, journalists and healthcare industry representatives from around the world. The Congress provides a global platform for advances in oncology research, clinical practice and patient care, featuring new scientific data, educational programming, networking opportunities and innovation across the oncology community. For more information, visit esmo.org.

About CytoDyn
CytoDyn is a clinical-stage oncology company dedicated to advancing leronlimab, a first-in-class humanized monoclonal antibody that targets the CCR5 receptor, a key regulator of immune function implicated in cancer, infectious diseases, and autoimmune disorders. Guided by a mission to improve patients’ quality of life through therapeutic innovation, CytoDyn is committed to integrity, responsibility, and service as it works to bring transformative treatments to patients worldwide.

For more information, please visit www.cytodyn.com and follow us on LinkedIn.

Note Regarding Forward-Looking Statements
This news release may contain forward-looking statements relating to, among other things, the mechanism of action of leronlimab, clinical trial results, product development, market position, future operating and financial performance, and business strategy. The reader is cautioned not to rely on these statements, which are based on current expectations of future events. For important information about these statements and our Company, including the risks, uncertainties and other factors that could cause actual results to vary materially from the assumptions, expectations and projections expressed in any forward-looking statements, the reader should review our Annual Report on Form 10-K for the fiscal year ended May 31, 2026, including the section captioned “Forward-Looking Statements” and in Item 1A, as well as subsequent reports filed with the Securities and Exchange Commission. CytoDyn Inc. does not undertake to update any forward-looking statement as a result of new information or future events or developments except as required by applicable law.

Corporate Contact
CytoDyn Inc.
ir@cytodyn.com

Media Contacts
David Schull or Ignacio Guerrero-Ros, Ph.D.
Russo Partners, LLC
CytoDyn@russopartnersllc.com

EAU CLAIRE, Wis., Oct. 26, 2026 (GLOBE NEWSWIRE) — Citizens Community Bancorp, Inc. (the “Company”) (Nasdaq: CZWI), the parent company of CCFBank N.A. (the “Bank” or “CCFBank”), today reported earnings of $5.4 million and earnings per diluted share of $0.56 for the third quarter ended September 30, 2026, compared to $1.1 million and earnings per diluted share of $0.11 for the second quarter ended June 30, 2026, and $3.7 million and $0.37 earnings per diluted share for the quarter ended September 30, 2025, respectively. For the nine months ended September 30, 2026, the Company reported earnings of $10.3 million and earnings per diluted share of $1.06 compared to the prior year period of $10.1 million and earnings per diluted share of $1.02.

Third quarter 2026 operating results reflected the following changes from the second quarter of 2026: (1) an increase in net interest income of $1.0 million largely due to a higher net interest margin of 15 basis points due to the impact of new loan originations and loans repricing; (2) a decrease in provision for credit losses of $4.2 million from $4.3 million the prior quarter; and (3) slightly higher non-interest income of $0.3 million largely due to higher loan servicing income and higher gains on equity securities.

Book value per share increased to $19.91 on September 30, 2026, compared to $19.83 at June 30, 2026, and increased from $18.95 at September 30, 2025. Tangible book value per share (non-GAAP)¹ was $16.62 at September 30, 2026, compared to $16.55 at June 30, 2026, and $15.71 at September 30, 2025. For the third quarter of 2026, the increase in tangible book value was due to quarterly net income, partially offset by both the impact of higher unrealized losses on the available-for-sale investment portfolio, and the quarterly dividend payment. Stockholders’ equity as a percentage of total assets was 10.62% at September 30, 2026, compared to 10.55% at June 30, 2026. Tangible common equity (“TCE”) as a percent of tangible assets (non-GAAP)¹ was 9.02% at September 30, 2026, compared to 8.96% at June 30, 2026.

“The strong quarter reflected continued execution of our strategic plan with lower provision expense and the net interest margin and margin dollar increase being the highlight. We also saw loan originations outpace a modest pickup in loan payoffs, ten percent higher non-interest income from the linked quarter and non-interest expenses were controlled other than higher variable performance-based compensation expense which accounted for the uptick from last quarter. Efforts to work through asset quality issues continued in the quarter. Net charge offs were $5 thousand and criticized loans increased at a slower rate from last quarter to $61.2 million. The number of relationships risk rated special mention or substandard is concentrated in ten relationships, which make up 70% of the above two risk ratings dollars. We believe these problem loan relationships represent individual company/management issues rather than a concentration or industry weakness.

Executive management has directed workout strategies for criticized loan relationships and led portfolio reviews during the quarter of select loan segments to enhance resolution efforts and align resources. We continue to monitor performance as updated borrower financial information is received.

Growth in capital through earnings absorbed unrealized losses in our securities portfolio and nudged our tangible capital ratio to 9.02%. Seventy thousand shares were repurchased in the quarter under the authorization announced in early September. On October 22, 2026, the board authorized an increase of the quarterly dividend by 14% to $0.12 per share. The board and management continue to work with our investment bankers on strategic opportunities in the best interest of our shareholders,” said Stephen Bianchi, Chairman, President, and CEO.

September 30, 2026, Highlights:

• Quarterly earnings were $5.4 million, or $0.56 per diluted share for the quarter ending September 30, 2026, an increase compared to earnings of $1.1 million, or $0.11 per diluted share for the quarter ended June 30, 2026, and an increase from $3.7 million, or $0.37 per diluted share for the quarter ended September 30, 2025.
• For the nine months ended September 30, 2026, earnings were $10.3 million or $1.06 per diluted share compared to $10.1 million or $1.02 per diluted share for the nine-month period one year earlier. The increase in earnings for the nine-month period primarily related to a $2.9 million increase in net interest income, higher non-interest income of $0.1 million, lower non-interest expenses of $0.4 million, lower income taxes of $0.2 million, partially offset by a $3.5 million increase in the provision for credit losses.
• Pre-provision net revenue (“PPNR”) increased 21.1% during the quarter ended September 30, 2026, to $6.74 million from $5.56 million for the quarter ended June 30, 2026, and increased 29.9% from $5.19 million for the third quarter of 2025.
• PPNR for the nine months ended September 30, 2026, increased 23.6% to $17.7 million from $14.3 million for the nine months ended September 30, 2025, largely due to increases in net interest income.
• Net interest income increased $1.0 million to $14.5 million for the quarter ended September 30, 2026, from $13.5 million for the quarter ended June 30, 2026, and increased from $13.2 million for the quarter ended September 30, 2025. The increase in net interest income from the second quarter of 2026 was primarily due to a 15 basis point increase in net interest margin, primarily due to a 17 basis point increase in loan yields from the prior quarter due to the impact of loans repricing and new loan production. In addition, the impact of a larger average balance of net interest earning assets increased net interest income by $0.2 million and the impact of one more day in the quarter added $0.1 million.
• The provision for credit losses was $0.13 million for the quarter ended September 30, 2026, compared to a provision for credit losses of $4.33 million for the second quarter of 2026. Factors affecting the third quarter provision for credit losses relative to the second quarter included lower specific reserves and charge-offs on nonaccrual loans, lower required ACL provisions based on changes in loan characteristics, offset by the impact of new loan growth. 
• Non-interest income increased by $0.3 million in the third quarter ended September 30, 2026, to $2.9 million from $2.6 million in the prior quarter and decreased $0.1 million from $3.0 million in the third quarter of 2025. The increase in the third quarter of 2026 from the second quarter of 2026 was primarily due to higher gains on equity securities and higher loan servicing income. The decrease in the third quarter of 2026 from the third quarter of 2025 was primarily due to lower gains on the sale of loans, partially offset by higher gains on equity securities, net.
• Non-interest expense increased $0.1 million to $10.6 million from $10.5 million for the previous quarter and decreased $0.4 million from $11.1 million for the third quarter of 2025. The increase in non-interest expense compared to the linked quarter was driven primarily by higher compensation costs, as third quarter incentive accruals reflected higher performance. Additionally, a one-time $0.1 million increase in data processing expense was more than offset by the decrease in other expenses, primarily related to a decrease in expenses related to credit quality. Non-interest expense in the third quarter of 2026 decreased $0.4 million from the third quarter of 2025, primarily due to data processing expenses. Amortization of intangible assets will decline in the fourth quarter as the remaining intangible will be fully amortized during the fourth quarter.
• The effective tax rate was 18.2% for the quarter ended September 30, 2026, compared to 10.9% for the quarter ended June 30, 2026, and 18.8% for the quarter ended September 30, 2025. The increase in the effective tax rate in the third quarter of 2026 from the second quarter of 2026 was due to the effective tax rate normalizing to historical levels after the extremely low effective rate in the second quarter of 2026 primarily due to the impact of lower net income in the second quarter.
• Loans receivable increased $5.9 million during the third quarter ended September 30, 2026, to $1.389 billion compared to the prior quarter end. The increase in loans reflected new commercial real estate and multi-family loan originations partially offset by reductions in C&I, agricultural and residential loans.
• Nonperforming assets decreased modestly by $0.2 million to $32.2 million at September 30, 2026, compared to $32.4 million at June 30, 2026. The non-guaranteed portion of the loans originated with partial government guarantees decreased $0.3 million to $0.9 million at September 30, 2026. There are specific reserves of approximately 25% on the non-guaranteed government loans.
• Special mention loans decreased $6.2 million to $13.7 million at September 30, 2026, from June 30, 2026, largely due to the migration of two loan relationships to substandard.
• Substandard loans increased $12.4 million to $47.6 million at September 30, 2026, from June 30, 2026, primarily due to the migration of two loan relationships from special mention and the addition of two other loans. One of the additional loans is a multi-family project experiencing cash flow reductions and the other is an office loan that is currently listed for sale. Established reserve levels for all substandard loans are believed to be adequate.
• Total deposits decreased $17.7 million during the quarter ended September 30, 2026, to $1.537 billion, and increased $56.1 million from the quarter ended September 30, 2025. The decrease in the third quarter of 2026 from the second quarter of 2026 was largely due to seasonal decreases in public deposits of $30.5 million partially offset by seasonal increases of $16.0 million in commercial deposits.
• The efficiency ratio was 61% for the quarter ended September 30, 2026, compared to 65% for the quarter ended June 30, 2026, and 67% for the quarter ended September 30, 2025. The decrease in the efficiency ratio was primarily related to the growth in net interest income.
• On October 22, 2026, the Board of Directors approved an increase in the quarterly dividend to $0.12 per share or a 14% increase. The dividend will be payable on November 20, 2026, to shareholders of record on November 6, 2026.
• On September 2, 2026, the Board of Directors approved a new 5% stock authorization or 482,500 shares. In the third quarter the Company repurchased 70,000 shares resulting in 412,500 shares remaining in the authorization.

Balance Sheet and Asset Quality

Total assets decreased by $18.7 million during the quarter to $1.796 billion at September 30, 2026.

Cash and cash equivalents decreased $26.3 million due to funding net new loan originations and seasonal reductions in public deposits.

The on-balance sheet liquidity ratio, which is defined as the fair market value of available-for-sale (“AFS”) and held-to-maturity (“HTM”) securities that are not pledged and cash on deposit with other financial institutions, was 13.1% of total assets at September 30, 2026, compared to 14.3% of total assets at June 30, 2026. On-balance sheet liquidity, collateralized new borrowing capacity, and uncommitted federal funds borrowing availability was $772 million, or 279% of uninsured and uncollateralized deposits at September 30, 2026, and $781 million, or 246% at June 30, 2026.

AFS securities increased $2.2 million during the quarter ended September 30, 2026, to $130.6 million from $128.4 million at June 30, 2026. The increase was largely related to the purchase of $10 million of two-year US Treasury notes and corporate debt securities of $3.0 million, offset by principal repayments and maturities of $3.3 million, corporate debt security redemptions of $4.1 million and a decrease in the market value of $3.4 million. HTM securities decreased $1.3 million to $76.1 million during the quarter ended September 30, 2026, from $77.4 million at June 30, 2026, due to principal repayments.

Loans receivable increased $5.9 million during the third quarter ended September 30, 2026, to $1.389 billion compared to the prior quarter end as loan growth was realized in commercial real estate and multi-family loans.

The office loan portfolio consisted of sixty-eight loans totaling $40 million at September 30, 2026, compared to seventy loans totaling $36 million at June 30, 2026. Criticized loans in the office loan portfolio for the quarter ended September 30, 2026, totaled $4.6 million, compared to $0.3 million at June 30, 2026, and there have been no charge-offs in office loans in the trailing twelve months. The Company has no non-depository financial institution loans as the one bank holding company loan for $5 million at June 30, 2026, paid off in the third quarter.

The allowance for credit losses on loans increased by $0.2 million to $26.1 million at September 30, 2026, representing 84% of total nonperforming loans and 1.88% of total loans compared to 1.87% of total loans receivable at June 30, 2026. The provision for credit losses was $0.13 million for the quarter ended September 30, 2026, compared to a provision for credit losses of $4.33 million for the quarter ended June 30, 2026, and a provision for credit losses of $0.65 million for the quarter ended September 30, 2025.

Allowance for Credit Losses (“ACL”) – Loans Percentage
(in thousands, except ratios)

		September 30, 2026				June 30, 2026				March 31, 2026				December 31, 2025
Loans, end of period		$	1,388,878			$	1,382,975			$	1,358,252			$	1,340,325
ACL – Loans		$	26,139			$	25,899			$	22,966			$	22,401
ACL – Loans as a percentage of loans, end of period			1.88	%			1.87	%			1.69	%			1.67	%

In addition to the ACL – Loans, the Company has established an ACL – Unfunded Commitments of $0.337 million at September 30, 2026, $0.457 million at June 30, 2026, and $0.493 million at September 30, 2025, classified in other liabilities on the consolidated balance sheets.

Allowance for Credit Losses – Unfunded Commitments
 (in thousands)

		September 30, 2026 and Three Months Ended				September 30, 2025 and Three Months Ended				September 30, 2026 and Nine Months Ended				September 30, 2025 and Nine Months Ended
ACL – Unfunded commitments, beginning of period		$	457			$	627			$	490			$	334
(Reversals)/additions to ACL – Unfunded commitments via provision for credit losses charged to operations			(120	)			(134	)			(153	)			159
ACL – Unfunded commitments, end of period		$	337			$	493			$	337			$	493

Nonperforming assets decreased by $0.2 million to $32.2 million at September 30, 2026, compared to $32.4 million at June 30, 2026. The non-guaranteed portion of the loans originated with partial government guarantees decreased $0.3 million to $0.9 million at September 30, 2026. There are specific reserves of approximately 25% on the non-guaranteed government loans.

Special mention loans decreased $6.2 million to $13.7 million at September 30, 2026, from $19.9 million at June 30, 2026. The decrease was largely due to the transfer of two relationships to substandard.

Substandard loans increased $12.4 million to $47.6 million at September 30, 2026, from June 30, 2026, primarily due to the migration of two loan relationships from special mention and the addition of two other loans. One of the additional loans is a multi-family project experiencing cash flow reductions and the other is an office loan that is currently listed for sale. Established reserve levels for all substandard loans are believed to be adequate.

		(in thousands)
		September 30, 2026			June 30, 2026			March 31, 2026			December 31, 2025			September 30, 2025
Special mention loan balances		$	13,654		$	19,863		$	25,894		$	24,473		$	12,920
Substandard loan balances			47,600			35,216			22,498			21,388			21,310
Criticized loans, end of period		$	61,254		$	55,079		$	48,392		$	45,861		$	34,230

Deposit Portfolio Composition
(in thousands)

		September 30, 2026			June 30, 2026			March 31, 2026			December 31, 2025			September 30, 2025
Consumer deposits		$	880,714		$	884,335		$	887,998		$	889,109		$	855,226
Commercial deposits			458,424			442,443			433,923			422,605			423,662
Public deposits			171,087			201,599			217,400			187,777			175,689
Wholesale deposits			26,467			26,040			26,301			24,608			25,977
Total deposits		$	1,536,692		$	1,554,417		$	1,565,622		$	1,524,099		$	1,480,554

At September 30, 2026, the deposit portfolio composition by percentages changed very modestly from the prior quarter and were 57.3% consumer, 29.9% commercial, 11.1% public, and 1.7% wholesale deposits.

Deposit Composition By Type
(in thousands)

		September 30, 2026			June 30, 2026			March 31, 2026			December 31, 2025			September 30, 2025
Non-interest-bearing demand deposits		$	271,690		$	274,822		$	271,396		$	264,394		$	262,535
Interest-bearing demand deposits			372,515			384,101			392,684			367,958			360,475
Savings accounts			138,208			145,390			152,487			151,525			157,317
Money market accounts			415,895			408,305			404,991			392,900			354,290
Certificate accounts			338,384			341,799			344,064			347,322			345,937
Total deposits		$	1,536,692		$	1,554,417		$	1,565,622		$	1,524,099		$	1,480,554

Uninsured and uncollateralized deposits were $277 million, or 18% of total deposits at September 30, 2026, and $313 million, or 20% of total deposits at June 30, 2026. Uninsured deposits alone at September 30, 2026, were $385 million, or 25% of total deposits and $479 million, or 31% of total deposits at June 30, 2026.

Federal Home Loan Bank advances remained at $0 at September 30, 2026, June 30, 2026, and September 30, 2025.

Review of Operations

Net interest income increased by $1.0 million to $14.5 million for the current quarter ended September 30, 2026, from $13.5 million for the prior quarter ended June 30, 2026, and increased from $13.2 million for the quarter ended September 30, 2025. The increase in net interest income from the second quarter of 2026 was primarily due to a 15 basis point increase in net interest margin, primarily due to a 17 basis point increase in loan yields from the prior quarter due to the impact of loans repricing and new loan originations. In addition, the impact of a larger average balance of net interest earning assets increased net interest income by $0.2 million and the impact of one more day in the quarter added $0.1 million.

Net Interest Income and Net Interest Margin Analysis
(in thousands, except yields and rates)

		Three Months Ended
		September 30, 2026							June 30, 2026							March 31, 2026							December 31, 2025							September 30, 2025
		Net Interest Income				Net Interest Margin			Net Interest Income				Net Interest Margin			Net Interest Income				Net Interest Margin			Net Interest Income				Net Interest Margin			Net Interest Income				Net Interest Margin
As reported		$	14,491			3.37	%		$	13,504			3.22	%		$	13,010			3.18	%		$	13,065			3.15	%		$	13,214			3.20	%
Less scheduled accretion for PCD loans			(5	)		—	%			(5	)		—	%			(4	)		—	%			(5	)		—	%			(17	)		—	%
Less paid loan accretion for PCD loans			—			—	%			(26	)		(0.01) %				10			—	%			—			—	%			(133	)		(0.03) %
Less scheduled accretion interest			—			—	%			—			—	%			—			—	%			—			—	%			(30	)		(0.01) %
Without loan purchase accretion		$	14,486			3.37	%		$	13,473			3.21	%		$	13,016			3.18	%		$	13,060			3.15	%		$	13,034			3.16	%

The table below shows the impact of loans, securities, and certificates contractual fixed rate maturing and repricing.

Portfolio Contractual Fixed Rate Repricing by Future Quarters:
(in millions, except yields)

		Q4 2026				Q1 2027				Q2 2027				Q3 2027				Q4 2027
Maturing or Repricing Loans:
Contractual balance		$	87			$	63			$	66			$	47			$	70
Contractual interest rate			4.21	%			4.52	%			4.64	%			5.17	%			5.39	%
Maturing or Repricing Securities:
Contractual balance		$	3			$	3			$	—			$	4			$	—
Contractual interest rate			3.27	%			3.31	%			—	%			5.92	%			—	%
Maturing Certificate Accounts:
Contractual balance		$	97			$	120			$	39			$	65			$	14
Contractual interest rate			3.70	%			3.63	%			3.62	%			3.73	%			3.77	%

Non-interest income increased by $0.3 million in the third quarter ended September 30, 2026, to $2.9 million from $2.6 million in the prior quarter and decreased $0.1 million from $3.0 million in the third quarter of 2025. The increase in the third quarter of 2026 from the second quarter of 2026 was primarily due to higher gains on equity securities and higher loan servicing income. The decrease in the third quarter of 2026 from the third quarter of 2025 was primarily due to lower gains on the sale of loans, partially offset by higher gains on equity securities.

Non-interest expense increased $0.1 million to $10.6 million from $10.5 million for the previous quarter and decreased $0.4 million from $11.1 million for the third quarter of 2025. The increase in non-interest expense compared to the linked quarter was driven primarily by higher compensation costs, as second quarter incentive accruals reflected a downward adjustment while the third quarter reflected a more normal level. Additionally, a one-time $0.1 million increase in data processing expense was more than offset by the decrease in other expenses, primarily related to a decrease in expenses related to credit quality. Non-interest expense in the third quarter of 2026 decreased $0.4 million from the third quarter of 2025, primarily due to data processing expenses. Amortization of intangible assets will decline, as the remaining intangible will be fully amortized during the fourth quarter.

The effective tax rate was 18.2% for the quarter ended September 30, 2026, compared to 10.9% for the quarter ended June 30, 2026, and 18.8% for the quarter ended September 30, 2025. The increase in the effective tax rate in the third quarter of 2026 from the second quarter of 2026 was due to the tax rate normalizing to historical levels after the extremely low effective tax rate in the second quarter of 2026 primarily due to the impact of lower net income in the second quarter.

Certain items previously reported may be reclassified for consistency with the current presentation. These financial results are preliminary until the Form 10-Q is filed in November 2026.

About the Company

Citizens Community Bancorp, Inc. (Nasdaq: “CZWI”) is the holding company of the Bank, a national bank based in Altoona, Wisconsin, currently serving customers primarily in Wisconsin and Minnesota through 21 branch locations. Its primary markets include the Chippewa Valley Region in Wisconsin, the Twin Cities and Mankato markets in Minnesota, and various rural communities around these areas. The Bank offers traditional community banking services to businesses, ag operators and consumers, including residential mortgage loans.

Cautionary Statement Regarding Forward-Looking Statements

Certain statements contained in this release are considered “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified using forward-looking words or phrases such as “anticipate,” “believe,” “could,” “expect,” “estimates,” “intend,” “may,” “on pace,” “preliminary,” “planned,” “potential,” “should,” “will,” “would” or the negative of those terms or other words of similar meaning. Similarly, statements that describe the Company’s future plans, objectives or goals are also forward-looking statements. Such forward-looking statements in this release are inherently subject to many uncertainties arising in the operations and business environment of the Company and the Bank. These uncertainties include: conditions in the financial markets and economic conditions generally; the impact of inflation on our business and our customers; geopolitical tensions, including current or anticipated impact of military conflicts; higher lending risks associated with our commercial and agricultural banking activities; future pandemics; cybersecurity risks; adverse impacts on the regional banking industry and the business environment in which the Company and the Bank operate; interest rate risk; lending risk; changes in the fair value or ratings downgrades of our securities; the sufficiency of allowance for credit losses; competitive pressures from others in the financial services industry, including non-depository institutions; disintermediation risk (including the use of emerging financial technologies such as cryptocurrencies); our ability to maintain our reputation; our ability to maintain or increase our market share; our ability to realize the benefits of net deferred tax assets; our ability to obtain needed liquidity; our ability to raise capital needed to fund growth or meet regulatory requirements; our ability to attract and retain key personnel; our ability to keep pace with technological change; prevalence of fraud and other financial crimes; the possibility that our internal controls and procedures could fail or be circumvented; our ability to successfully execute our acquisition growth strategy; risks posed by acquisitions and other expansion opportunities, including difficulties and delays in integrating acquired business operations or fully realizing the cost savings and other benefits; restrictions on our ability to pay dividends; volatility of our stock price (including possible removal from the Russell 3000^® Index and related indexes); accounting standards for credit losses; legislative or regulatory changes or actions, or significant litigation, adversely affecting the Company or Bank; public company reporting obligations; changes in federal or state tax laws; and changes in accounting principles, policies or guidelines and their impact on financial performance. Stockholders, potential investors, and other readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. Such uncertainties and other risks that may affect the Company’s performance are discussed further in Part I, Item 1A, “Risk Factors,” in the Company’s Form 10-K, for the year ended December 31, 2025, filed with the Securities and Exchange Commission (“SEC”) on March 5, 2026, and the Company’s subsequent filings with the SEC. The forward-looking statements made herein are only made as of the date of this release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances occurring after the date of this release.

¹ Non-GAAP Financial Measures

This press release contains non-GAAP financial measures, such as tangible book value, tangible book value per share, tangible common equity as a percent of tangible assets and return on average tangible common equity, which management believes may be helpful in understanding the Company’s results of operations or financial position and comparing results over different periods.

Tangible book value, tangible book value per share, tangible common equity as a percentage of tangible assets and return on average tangible common equity are non-GAAP measures that eliminate the impact of goodwill and intangible assets on our financial position. Management believes these measures are useful in assessing the strength of our financial position.

Where non-GAAP financial measures are used, the comparable GAAP financial measure, as well as the reconciliation to the comparable GAAP financial measure, can be found in this press release. These disclosures should not be viewed as a substitute for operating results determined in accordance with GAAP, nor are they necessarily comparable to non-GAAP performance measures that may be presented by other banks and financial institutions.

Contact: Steve Bianchi, CEO
(715)-836-9994

(CZWI-ER)

CITIZENS COMMUNITY BANCORP, INC. Consolidated Balance Sheets (in thousands, except share data)
		September 30, 2026 (unaudited)				June 30, 2026 (unaudited)				December 31, 2025 (audited)				September 30, 2025 (unaudited)
Assets
Cash and cash equivalents		$	95,444			$	121,762			$	118,853			$	82,431
Securities available-for-sale (“AFS”)			130,593				128,435				134,103				137,639
Securities held-to-maturity (“HTM”)			76,065				77,415				80,210				81,526
Equity investments			6,556				6,287				5,840				5,675
Other investments			12,476				12,485				12,506				12,370
Loans receivable			1,388,878				1,382,975				1,340,325				1,323,010
Allowance for credit losses			(26,139	)			(25,899	)			(22,401	)			(22,182	)
Loans receivable, net			1,362,739				1,357,076				1,317,924				1,300,828
Loans held for sale			1,559				941				4,954				5,346
Mortgage servicing rights, net			3,506				3,453				3,494				3,532
Office properties and equipment, net			17,338				17,441				16,357				16,244
Accrued interest receivable			6,436				6,180				6,126				6,159
Intangible assets			56				169				395				508
Goodwill			31,498				31,498				31,498				31,498
Foreclosed and repossessed assets, net			1,090				850				857				911
Bank owned life insurance (“BOLI”)			27,564				27,342				26,908				26,700
Other assets			22,737				22,975				21,730				15,620
TOTAL ASSETS		$	1,795,657			$	1,814,309			$	1,781,755			$	1,726,987
Liabilities and Stockholders’ Equity
Liabilities:
Deposits		$	1,536,692			$	1,554,417			$	1,524,099			$	1,480,554
Federal Home Loan Bank (“FHLB”) advances			—				—				—				—
Other borrowings			51,925				51,885				51,804				46,762
Other liabilities			16,299				16,659				17,913				12,856
Total liabilities			1,604,916				1,622,961				1,593,816				1,540,172
Stockholders’ Equity:
Common stock— $0.01 par value, authorized 30,000,000; 9,579,231, 9,650,231, 9,617,245, and 9,856,745 shares issued and outstanding, respectively			96				97				96				99
Additional paid-in capital			109,670				110,454				110,315				113,030
Retained earnings			96,464				92,820				89,995				86,913
Accumulated other comprehensive loss			(15,489	)			(12,023	)			(12,467	)			(13,227	)
Total stockholders’ equity			190,741				191,348				187,939				186,815
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY		$	1,795,657			$	1,814,309			$	1,781,755			$	1,726,987

CITIZENS COMMUNITY BANCORP, INC. Consolidated Statements of Operations (in thousands, except per share data)
		Three Months Ended												Nine Months Ended
		September 30, 2026 (unaudited)				June 30, 2026 (unaudited)				September 30, 2025 (unaudited)				September 30, 2026 (unaudited)				September 30, 2025 (unaudited)
Interest and dividend income:
Interest and fees on loans		$	20,407			$	19,322			$	19,759			$	58,498			$	58,466
Interest on cash and investments			2,793				2,712				2,495				8,252				7,393
Total interest and dividend income			23,200				22,034				22,254				66,750				65,859
Interest expense:
Interest on deposits			7,990				7,819				8,220				23,600				25,104
Interest on FHLB borrowed funds			—				1				1				1				13
Interest on other borrowed funds			719				710				819				2,144				2,623
Total interest expense			8,709				8,530				9,040				25,745				27,740
Net interest income before provision for credit losses			14,491				13,504				13,214				41,005				38,119
Provision for credit losses			125				4,325				650				5,200				1,750
Net interest income after provision for credit losses			14,366				9,179				12,564				35,805				36,369
Non-interest income:
Service charges on deposit accounts			491				460				449				1,411				1,304
Interchange income			555				556				565				1,612				1,647
Loan servicing income			681				593				649				1,935				1,773
Gain on sale of loans			489				442				992				1,952				2,411
Loan fees and service charges			131				129				173				398				530
Net gains (losses) on equity securities			256				160				(66	)			357				43
Other			279				267				260				923				743
Total non-interest income			2,882				2,607				3,022				8,588				8,451
Non-interest expense:
Compensation and related benefits			6,189				5,712				6,341				17,967				17,946
Occupancy			1,202				1,240				1,266				3,720				3,749
Data processing			1,381				1,302				1,811				4,100				5,283
Amortization of intangible assets			113				113				113				339				471
Mortgage servicing rights expense, net			121				173				161				455				449
Advertising, marketing and public relations			190				207				201				623				562
FDIC premium assessment			195				200				195				626				584
Professional services			353				514				359				1,472				1,299
Gains on repossessed assets, net			(61	)			(12	)			(4	)			(73	)			—
Other			953				1,100				608				2,683				1,921
Total non-interest expense			10,636				10,549				11,051				31,912				32,264
Income before provision for income taxes			6,612				1,237				4,535				12,481				12,556
Provision for income taxes			1,206				135				853				2,218				2,407
Net income attributable to common stockholders		$	5,406			$	1,102			$	3,682			$	10,263			$	10,149
Per share information:
Basic earnings		$	0.56			$	0.11			$	0.37			$	1.07			$	1.02
Diluted earnings		$	0.56			$	0.11			$	0.37			$	1.06			$	1.02
Cash dividends paid		$	0.105			$	0.105			$	—			$	0.315			$	0.36
Book value per share at end of period		$	19.91			$	19.83			$	18.95			$	19.91			$	18.95
Tangible book value per share at end of period (non-GAAP)		$	16.62			$	16.55			$	15.71			$	16.62			$	15.71

Loan Composition
(in thousands)

		September 30, 2026				June 30, 2026				December 31, 2025				September 30, 2025
Total Loans:
Commercial/Agricultural real estate:
Commercial real estate		$	743,657			$	731,028			$	683,108			$	683,931
Agricultural real estate			72,903				71,382				69,136				64,096
Multi-family real estate			261,803				253,244				245,688				237,191
Construction and land development			57,877				56,090				75,767				74,789
C&I/Agricultural operating:
Commercial and industrial			104,770				117,215				105,907				101,700
Agricultural operating			26,676				29,427				33,375				30,085
Residential mortgage:
Residential mortgage			114,190				117,083				122,025				125,198
Purchased HELOC loans			1,384				1,405				1,739				1,979
Consumer installment:
Originated indirect paper			1,301				1,559				2,224				2,567
Other consumer			7,013				7,267				3,997				4,155
Gross loans		$	1,391,574			$	1,385,700			$	1,342,966			$	1,325,691
Unearned net deferred fees and costs and loans in process			(2,614	)			(2,638	)			(2,528	)			(2,563	)
Unamortized discount on acquired loans			(82	)			(87	)			(113	)			(118	)
Total loans receivable		$	1,388,878			$	1,382,975			$	1,340,325			$	1,323,010

Nonperforming Assets
Loan balances at amortized cost
(in thousands, except ratios)

		September 30, 2026				June 30, 2026				December 31, 2025				September 30, 2025
Nonperforming Assets:
Nonaccrual loans
Commercial real estate		$	18,403			$	18,676			$	4,652			$	4,592
Agricultural real estate			2,233				2,254				464				220
Multi-family real estate			8,970				8,970				8,970				8,970
Construction and land development			—				—				—				—
Commercial and industrial (“C&I”)			935				1,221				1,282				1,312
Agricultural operating			—				—				—				—
Residential mortgage			416				440				485				520
Consumer installment			—				—				—				—
Total nonaccrual loans		$	30,957			$	31,561			$	15,853			$	15,614
Accruing loans past due 90 days or more			158				18				1				137
Total nonperforming loans (“NPLs”) at amortized cost			31,115				31,579				15,854				15,751
Foreclosed and repossessed assets, net			1,090				850				857				911
Total nonperforming assets (“NPAs”)		$	32,205			$	32,429			$	16,711			$	16,662
Loans, end of period		$	1,388,878			$	1,382,975			$	1,340,325			$	1,323,010
Total assets, end of period		$	1,795,657			$	1,814,309			$	1,781,755			$	1,726,987
Ratios:
NPLs to total loans			2.24	%			2.28	%			1.18	%			1.19	%
NPAs to total assets			1.79	%			1.79	%			0.94	%			0.96	%

Average Balances, Interest Yields and Rates
(in thousands, except yields and rates)

		Three Months Ended September 30, 2026									Three Months Ended June 30, 2026									Three Months Ended September 30, 2025
		Average Balance			Interest Income/ Expense			Average Yield/ Rate			Average Balance			Interest Income/ Expense			Average Yield/ Rate			Average Balance			Interest Income/ Expense			Average Yield/ Rate
Average interest earning assets:
Cash and cash equivalents		$	104,272		$	978		3.72	%		$	98,575		$	908		3.69	%		$	62,395		$	693		4.41	%
Loans receivable			1,385,049			20,407		5.85	%			1,363,849			19,322		5.68	%			1,342,635			19,759		5.84	%
Investment securities			205,178			1,660		3.21	%			209,228			1,650		3.16	%			220,213			1,738		3.13	%
Other investments			12,481			155		4.93	%			12,491			154		4.95	%			12,373			64		2.05	%
Total interest earning assets		$	1,706,980		$	23,200		5.39	%		$	1,684,143		$	22,034		5.25	%		$	1,637,616		$	22,254		5.39	%
Average interest-bearing liabilities:
Savings accounts		$	142,927		$	242		0.67	%		$	148,055		$	276		0.75	%		$	158,905		$	306		0.76	%
Demand deposits			391,498			1,951		1.98	%			389,098			1,862		1.92	%			376,145			2,061		2.17	%
Money market accounts			414,557			2,675		2.56	%			401,145			2,534		2.53	%			358,956			2,512		2.78	%
CD’s			339,514			3,122		3.65	%			342,800			3,147		3.68	%			339,566			3,341		3.90	%
Total deposits		$	1,288,496		$	7,990		2.46	%		$	1,281,098		$	7,819		2.45	%		$	1,233,572		$	8,220		2.64	%
FHLB advances and other borrowings			51,905			719		5.50	%			51,920			711		5.49	%			54,389			820		5.98	%
Total interest-bearing liabilities		$	1,340,401		$	8,709		2.58	%		$	1,333,018		$	8,530		2.57	%		$	1,287,961		$	9,040		2.78	%
Net interest income					$	14,491								$	13,504								$	13,214
Interest rate spread								2.81	%								2.68	%								2.61	%
Net interest margin								3.37	%								3.22	%								3.20	%
Average interest earning assets to average interest-bearing liabilities								1.27									1.26									1.27

		Nine Months Ended September 30, 2026									Nine Months Ended September 30, 2025
		Average Balance			Interest Income/ Expense			Average Yield/ Rate			Average Balance			Interest Income/ Expense			Average Yield/ Rate
Average interest earning assets:
Cash and cash equivalents		$	102,827		$	2,847		3.70	%		$	51,589		$	1,710		4.43	%
Loans receivable			1,359,323			58,498		5.75	%			1,353,030			58,466		5.78	%
Investment securities			209,572			4,940		3.15	%			223,985			5,282		3.15	%
Other investments			12,492			465		4.98	%			12,423			401		4.32	%
Total interest earning assets		$	1,684,214		$	66,750		5.30	%		$	1,641,027		$	65,859		5.37	%
Average interest-bearing liabilities:
Savings accounts		$	147,728		$	827		0.75	%		$	162,222		$	1,048		0.86	%
Demand deposits			385,918			5,581		1.93	%			377,051			6,079		2.16	%
Money market accounts			403,295			7,717		2.56	%			361,944			7,557		2.79	%
CD’s			342,251			9,476		3.70	%			342,077			10,420		4.07	%
Total deposits		$	1,279,192		$	23,601		2.47	%		$	1,243,294		$	25,104		2.70	%
FHLB advances and other borrowings			51,883			2,144		5.52	%			60,231			2,636		5.85	%
Total interest-bearing liabilities		$	1,331,075		$	25,745		2.59	%		$	1,303,525		$	27,740		2.85	%
Net interest income					$	41,005								$	38,119
Interest rate spread								2.71	%								2.52	%
Net interest margin								3.26	%								3.11	%
Average interest earning assets to average interest bearing liabilities								1.27									1.26

Wholesale Deposits
(in thousands)

		September 30, 2026			June 30, 2026			March 31, 2026			December 31, 2025			September 30, 2025
Brokered money market accounts			5,263			5,229			5,495			5,168			5,131
Third party originated reciprocal deposits			21,204			20,811			20,806			19,440			20,846
Total wholesale deposits		$	26,467		$	26,040		$	26,301		$	24,608		$	25,977

Key Financial Metric Ratios:

		Three Months Ended									Nine Months Ended
		September 30, 2026			June 30, 2026			September 30, 2025			September 30, 2026			September 30, 2025
Ratios based on net income:
Return on average assets (annualized)		1.18	%		0.25	%		0.84	%		0.76	%		0.78	%
Return on average equity (annualized)		11.21	%		2.32	%		7.90	%		7.21	%		7.48	%
Return on average tangible common equity1(annualized)		13.70	%		3.03	%		9.80	%		8.88	%		9.43	%
Efficiency ratio		61	%		65	%		67	%		64	%		68	%
Net interest margin with loan purchase accretion		3.37	%		3.22	%		3.20	%		3.26	%		3.11	%
Net interest margin without loan purchase accretion		3.37	%		3.21	%		3.16	%		3.25	%		3.05	%

Reconciliation of Return on Average Assets
(in thousands, except ratios)

		Three Months Ended												Nine Months Ended
		September 30, 2026				June 30, 2026				September 30, 2025				September 30, 2026				September 30, 2025
GAAP earnings after income taxes		$	5,406			$	1,102			$	3,682			$	10,263			$	10,149
Average assets		$	1,813,413			$	1,803,346			$	1,735,752			$	1,797,463			$	1,746,423
Return on average assets (annualized)			1.18	%			0.25	%			0.84	%			0.76	%			0.78	%

Reconciliation of Return on Average Equity
(in thousands, except ratios)

		Three Months Ended												Nine Months Ended
		September 30, 2026				June 30, 2026				September 30, 2025				September 30, 2026				September 30, 2025
GAAP earnings after income taxes		$	5,406			$	1,102			$	3,682			$	10,263			$	10,149
Average equity		$	191,289			$	190,897			$	184,822			$	190,405			$	181,513
Return on average equity (annualized)			11.21	%			2.32	%			7.90	%			7.21	%			7.48	%

Reconciliation of Return on Average Tangible Common Equity (non-GAAP)
(in thousands, except ratios)

		Three Months Ended												Nine Months Ended
		September 30, 2026				June 30, 2026				September 30, 2025				September 30, 2026				September 30, 2025
Total stockholders’ equity		$	190,741			$	191,348			$	186,815			$	190,741			$	186,815
Less: Goodwill			(31,498	)			(31,498	)			(31,498	)			(31,498	)			(31,498	)
Less: Intangible assets			(56	)			(169	)			(508	)			(56	)			(508	)
Tangible common equity (non-GAAP)		$	159,187			$	159,681			$	154,809			$	159,187			$	154,809
Average tangible common equity (non-GAAP)		$	159,174			$	159,174			$	152,759			$	158,682			$	149,292
GAAP earnings after income taxes			5,406				1,102				3,682				10,263				10,149
Amortization of intangible assets, net of tax			92				101				92				279				381
Tangible net income		$	5,498			$	1,203			$	3,774			$	10,542			$	10,530
Return on average tangible common equity (annualized)			13.70	%			3.03	%			9.80	%			8.88	%			9.43	%

Reconciliation of Efficiency Ratio
(in thousands, except ratios)

		Three Months Ended												Nine Months Ended
		September 30, 2026				June 30, 2026				September 30, 2025				September 30, 2026				September 30, 2025
Non-interest expense (GAAP)		$	10,636			$	10,549			$	11,051			$	31,912			$	32,264
Less amortization of intangibles			(113	)			(113	)			(113	)			(339	)			(471	)
Efficiency ratio numerator (GAAP)		$	10,523			$	10,436			$	10,938			$	31,573			$	31,793
Non-interest income		$	2,882			$	2,607			$	3,022			$	8,588			$	8,451
Add back net losses on debt and equity securities			—				—				(66	)			—				—
Subtract net gains on debt and equity securities			256				160				—				357				43
Net interest income			14,491				13,504				13,214				41,005				38,119
Efficiency ratio denominator (GAAP)		$	17,117			$	15,951			$	16,302			$	49,236			$	46,527
Efficiency ratio (GAAP)			61	%			65	%			67	%			64	%			68	%

Pre-Provision Net Revenue (PPNR)
(in thousands, except yields and rates)

		Three Months Ended
		September 30, 2026			June 30, 2026			March 31, 2026			December 31, 2025			September 30, 2025			June 30, 2025			March 31, 2025
Pre-tax income		$	6,612		$	1,237		$	4,632		$	4,885		$	4,535		$	4,047		$	3,974
Add back provision for credit losses			125			4,325			750			200			650			1,350			—
Subtract provision reversal for credit losses			—			—			—			—			—			—			(250	)
Pre-provision net revenue		$	6,737		$	5,562		$	5,382		$	5,085		$	5,185		$	5,397			3,724

Reconciliation of Tangible Book Value Per Share (non-GAAP)
(in thousands, except per share data)

Tangible book value per share at end of period		September 30, 2026				June 30, 2026				March 31, 2026				December 31, 2025				September 30, 2025
Total stockholders’ equity		$	190,741			$	191,348			$	190,874			$	187,939			$	186,815
Less: Goodwill			(31,498	)			(31,498	)			(31,498	)			(31,498	)			(31,498	)
Less: Intangible assets			(56	)			(169	)			(282	)			(395	)			(508	)
Tangible common equity (non-GAAP)		$	159,187			$	159,681			$	159,094			$	156,046			$	154,809
Ending common shares outstanding			9,579,231				9,650,231				9,628,612				9,617,245				9,856,745
Book value per share		$	19.91			$	19.83			$	19.82			$	19.54			$	18.95
Tangible book value per share (non-GAAP)		$	16.62			$	16.55			$	16.52			$	16.23			$	15.71

Reconciliation of Tangible Common Equity as a Percent of Tangible Assets (non-GAAP)
(in thousands, except ratios)

Tangible common equity as a percent of tangible assets at end of period		September 30, 2026				June 30, 2026				March 31, 2026				December 31, 2025				September 30, 2025
Total stockholders’ equity		$	190,741			$	191,348			$	190,874			$	187,939			$	186,815
Less: Goodwill			(31,498	)			(31,498	)			(31,498	)			(31,498	)			(31,498	)
Less: Intangible assets			(56	)			(169	)			(282	)			(395	)			(508	)
Tangible common equity (non-GAAP)		$	159,187			$	159,681			$	159,094			$	156,046			$	154,809
Total assets			1,795,657				1,814,309			$	1,822,974			$	1,781,755			$	1,726,987
Less: Goodwill			(31,498	)			(31,498	)			(31,498	)			(31,498	)			(31,498	)
Less: Intangible assets			(56	)			(169	)			(282	)			(395	)			(508	)
Tangible assets (non-GAAP)		$	1,764,103			$	1,782,642			$	1,791,194			$	1,749,862			$	1,694,981
Total stockholders’ equity to total assets ratio			10.62	%			10.55	%			10.47	%			10.55	%			10.82	%
Tangible common equity as a percent of tangible assets (non-GAAP)			9.02	%			8.96	%			8.88	%			8.92	%			9.13	%

¹Tangible book value, tangible book value per share, tangible common equity as a percent of tangible assets and return on tangible common equity are non-GAAP measures that management believes enhance investors’ ability to understand the Company’s financial position. For a detailed reconciliation of GAAP to non-GAAP results, see the accompanying financial tables “Reconciliation of tangible book value per share (non-GAAP)”, “Reconciliation of tangible common equity as a percent of tangible assets (non-GAAP)”, and “Reconciliation of return on average tangible common equity (non-GAAP)”.